Systems, Devices, and Methods Having Stent Frame Features - Patent application
A double-walled stent structure with a leaflet valve attachment addresses the challenges of transcatheter mitral valve replacement by ensuring secure sealing and reducing complexity, enhancing the success of mitral valve replacement therapies.
Patent Information
- Application Number
- JP2024557872
- Authority / Receiving Office
- JP · JP
- Patent Type
- Applications
- Current Assignee / Owner
- Priority Date
- 2021-12-13
- Filing Date
- 2022-12-12
- Publication Date
- 2024-11-28
AI Technical Summary
Current transcatheter mitral valve replacement therapies face challenges due to anatomical and physiological complexities of the mitral valve, including issues with sealing and securing the replacement valve and supporting the leaflet valve, leading to high delivery failure rates and bulkiness for transcatheter delivery.
A double-walled stent structure with a stent cover and attached leaflet valve, where the inner wall is configured to seal and secure the native valve anatomy while being spaced from the outer wall, allowing for independent expansion and collapse, reducing the risk of outflow tract obstruction and functional impairment, and facilitating transcatheter delivery.
The double-walled stent design provides structural integrity, reduces complexity, and enables collapsibility for transcatheter delivery, improving the success rate of mitral valve replacement by addressing anatomical and physiological challenges.
Smart Images

Figure 2024544353000001_ABST
Abstract
Description
[Technical field]
[0001] CROSS-REFERENCE TO RELATED APPLICATIONS This application claims priority to U.S. Provisional Patent Application No. 63 / 289,078, entitled "SYSTEMS, DEVICES, AND METHODS HAVING STENT FRAME FEATURES," filed December 13, 2021, which is incorporated by reference herein in its entirety and for all purposes. [Background technology]
[0002] This patent application relates generally to the treatment of valvular disease, and more specifically to methods and devices for minimally invasive mitral valve replacement.
[0003] Valvular heart disease represents a significant burden for patients and healthcare systems, with a prevalence of 2 to 3% worldwide and increasing prevalence in ageing societies. Valvular disease can result from a variety of etiologies, including autoimmune, infectious, and degenerative causes. The epidemiology of valvular disease also varies according to the affected valve, with rheumatic heart disease being the leading cause of primary mitral regurgitation and mitral stenosis worldwide, while secondary mitral valve disease due to left ventricular dysfunction is more common in developed countries.
[0004] Current clinical guidelines from the American Heart Association and American College of Cardiology recommend transcatheter mitral valve repair for certain patient populations, although surgical repair and replacement remain the mainstay of most mitral valve repairs. In their 2017 Focus Update and 2014 Valve Disease Patient Management Guidelines, the AHA / ACC recommends percutaneous mitral balloon commissurotomy for severe mitral stenosis and transcatheter mitral valve repair for certain severely symptomatic patients with severe primary mitral regurgitation who are not surgical candidates due to comorbid conditions and have a reasonable life expectancy. Summary of the Invention
[0005] Further growth of transcatheter mitral valve therapies is hampered by the challenging anatomy and physiology of the mitral valve compared to more established transcatheter aortic valve therapies. For example, some mitral valve replacement procedures under development compromise the sealing and fixation of the outer portion of the replacement valve with the support of the leaflet valve. Other therapies attempt to address this challenge with bipartite replacement valve structures, but these therapies may have high delivery failure rates or may be too large for transcatheter delivery.
[0006] To address these issues, embodiments described herein relate to a replacement heart valve comprising a one-piece folded double-walled stent with a stent cover and leaflet valves attached to the lumen of the stent. The double-walled stent structure isolates or reduces the influence of the shape of the retention structure on the shape of the valve support, including the effects of external forces acting through the annulus during the cardiac cycle and non-circular annulus shapes. The double-walled stent structure allows the valve support to have a different size and shape than the outer annular support without conforming to the native anatomy. This can reduce the risk of outflow tract obstruction and / or dysfunction due to ventricular contraction, as the outer wall has a shorter longitudinal length than the inner wall supporting the leaflets. The one-piece design can allow for greater structural integrity by reducing the complexities associated with force concentrations between bonded, welded, or mechanically connected support components and / or their in situ attachment.
[0007] In some variations, this allows the expandable valve to be contracted to a size less than 29F, e.g., less than 10mm, or between 24F and 29F, or between 8mm and 10mm. The heart valve may be delivered using a multi-pulley, suture-based stent restraint assembly on the catheter or delivery tool. Guide openings or structures fixed along the distal end of the delivery system allow for independent expansion of the distal and proximal ends of the outer wall of the stent via sutures passing through the openings. Control of the expansion of the inner wall may occur simultaneously or independently of the expansion of the outer wall. The dual-walled one-piece design reduces complexity over valves with multi-component structures by separating the shape of the valve support from the retaining structure while providing collapsibility suitable for transcatheter delivery.
[0008] In one example, a replacement heart valve is provided that includes a one-piece stent frame having a folded double wall. The stent frame includes an outer wall having a collapsed configuration and an expanded configuration, an open expanded region, an intermediate reduced diameter region, and a closed expanded region, a tubular inner wall having a central lumen, a transition wall between the outer wall and the inner wall, and a replacement leaflet valve disposed in the central lumen of the inner wall. The one-piece stent frame may further include a first fold between the closed expanded region and the tubular inner wall. The one-piece stent frame may further include a second fold between the closed expanded region and the open expanded region. The outer wall may surround at least 70% of the inner wall in the expanded configuration. The outer wall and the transition wall may completely surround the inner wall in the collapsed configuration. The tubular inner wall may include a non-shortening region that surrounds the replacement valve when transitioning from the collapsed configuration to the expanded configuration. The inner wall may be a non-shortening inner wall and the outer wall may be a shortening outer wall. The radius of curvature of the first fold may be less than the radius of curvature of the second fold. The integral stent frame may include a plurality of longitudinal struts, each longitudinal strut being disposed consecutively along the inner wall, the transition wall, and the outer wall. In some variations, for at least one or all of the plurality of longitudinal struts, consecutive segments of the longitudinal struts located on the inner wall, the transition wall, and the outer wall are coplanar. The consecutive segments of the longitudinal struts may be coplanar with a central longitudinal axis of the integral stent frame. The plurality of longitudinal struts may be integrally formed with the plurality of circumferential struts. In some examples, at least three circumferential struts are disposed on the outer wall. The valve may further include a stent cover comprising a first region on the outer surface of the outer wall, a second region on the open end of the outer wall, a third region on the outer surface of the transition wall, a fourth region on the inner surface of the inner wall, a fifth region on the open end of the inner wall, a sixth region on the outer surface of the inner wall, a seventh region on the inner surface of the outer wall, and a portion of an eighth region between the inner surface of the outer wall and the outer surface of the inner wall. The first, second, and third regions and a portion of the fourth region may comprise a first fabric structure, the fourth region and a portion of the fifth region may comprise a second fabric structure, and the sixth, seventh, and eighth regions may comprise a third fabric structure.The first and third fabric structures may comprise a first fabric material, and the second fabric structure may comprise a second fabric material different from the first fabric material. The first fabric material may be less breathable and thinner than the second fabric material. The plurality of longitudinal struts and the plurality of circumferential struts may comprise segmented annular cross-sectional shapes, and an orientation of the segmented annular cross-sectional shapes at the inner wall is opposite to an orientation of the segmented annular cross-sectional shapes at the outer wall.
[0009] In another embodiment, a replacement heart valve is provided that includes a one-piece stent frame having a folded double wall, the stent frame having an outer wall with an open expanding region, an intermediate reduced diameter region, and a closed expanding region, a cylindrical inner wall with a central lumen, and a transition surface between the outer wall and the inner wall, the replacement heart valve including a replacement leaflet valve disposed in the central lumen of the inner wall. The one-piece stent frame may further include a plurality of longitudinal struts, each longitudinal strut including a longitudinal outer wall segment contiguous with a transition surface segment and a longitudinal inner wall segment. In at least one of the plurality of longitudinal struts, the longitudinal outer wall segment, the transition surface segment, and the longitudinal inner wall segment may be continuously coplanar. The one-piece stent frame may include a central longitudinal axis, and the continuously coplanar longitudinal outer wall segment, the transition surface segment, and the longitudinal inner wall segment of each of at least one of the plurality of longitudinal struts are coplanar with the central longitudinal axis. In some examples, adjacent ones of the plurality of longitudinal struts may be circumferentially formed with a plurality of chevron struts. Each of the plurality of longitudinal struts may comprise a continuously coplanar outer longitudinal wall segment, a transition surface segment, and an inner longitudinal wall segment. The one-piece stent frame may have a relatively small radius of curvature at the transition junction between the outer wall and the transition surface and a relatively large radius of curvature at the transition junction between the transition surface and the inner wall.
[0010] In yet another example, a stent may be provided that includes a one-piece dual-wall expandable stent frame having a central opening and a central axis and includes an expanded configuration and a contracted configuration. The stent frame may be a folded stent frame. The folded stent frame may be an inverted stent frame or an inverted stent frame. The stent frame may include a circumferential inner wall, the inner wall including an open end, a transition end, and an inner and outer surface therebetween, a circumferential outer wall, the outer wall including an open end, a transition end, and an inner and outer surface therebetween, and a transition wall between the transition ends of the inner and outer walls. The inner wall of the stent frame may be non-shortened in the expanded configuration relative to the contracted configuration. The stent frame may further include an annular cavity between the inner and outer walls, the cavity including an annular closed end at the transition wall and an annular open end between the open ends of the inner and outer walls. The outer wall may include an intermediate region having a reduced cross-sectional area in the expanded configuration compared to the cross-sectional area at the end regions of the outer wall. The inner wall may have a cylindrical or frustoconical shape. In the contracted configuration, the inner surface of the outer wall may be spaced close to the outer surface of the inner wall, and in the expanded configuration, the inner surface of the outer wall is spaced longitudinally distal from the outer surface of the inner wall relative to the contracted configuration. The stent frame may further comprise a first delivery configuration in which the transition ends of the inner and outer walls are partially in the expanded configuration and the open ends of the inner and outer walls are partially in the contracted configuration. The transition wall may have a transverse orientation relative to the central axis in the expanded configuration and a longitudinal orientation relative to the central longitudinal axis in the contracted configuration and a radially outward position relative to the inner wall. The stent frame may have a smaller radius of curvature at the transition end of the outer wall relative to a larger radius of curvature at the transition end of the inner wall, or a larger radius of curvature between the open and transition ends of the outer wall relative to a smaller radius of curvature at the transition end of the outer wall. The stent frame includes a plurality of longitudinal struts, each longitudinal strut including a radially aligned longitudinal outer wall segment continuous with a longitudinal inner wall segment via a transition wall segment, and adjacent ones of the longitudinal struts may be circumferentially spaced apart via a plurality of chevron struts.Each chevron strut of the plurality of chevron struts may comprise a first and a second leg, each leg having a proximal end integrally formed with one of the adjacent longitudinal struts and a distal end integrally formed with the distal end of the other leg. The integrally formed distal ends of the first and second legs may comprise a hairpin configuration. At least some of the plurality of chevron struts may be oriented in a tangent plane defined by adjacent longitudinal strut segments with which each chevron strut is integrally formed. At least one of the plurality of chevron struts may be oriented radially out of plane from the tangent plane. The out-of-plane chevron strut may be integrally formed with adjacent longitudinal struts at the outer wall, the hairpin configuration protruding into the reduced diameter region of the stent frame and pointing toward the transition end of the outer wall. In some variations, the stent may further comprise a leaflet valve sewn to the inner wall. The plurality of chevron struts may comprise a plurality of undulating circumferential struts. The stent may include a first fabric covering including an outer cuff covering a portion of the outer surface of the outer wall, an open end of the outer wall, and a portion of the inner surface of the outer wall, and a second fabric covering covering a portion of the outer surface of the outer wall, a transition wall, and a portion of the inner surface of the inner wall. The open end of the inner wall may be offset from the open end of the outer wall along the central longitudinal axis.
[0011] In yet another embodiment, a replacement heart valve is provided comprising a one-piece stent frame having a folded, double-walled, hourglass shape, the stent frame comprising an outer wall having an hourglass shape, the hourglass shape comprising an outer wall including an open expanding region, an intermediate reduced diameter region, and a closed expanding region, a non-shortening tubular inner wall having a central lumen, and a transition wall between the outer wall and the inner wall, the replacement heart valve comprising replacement leaflet valves disposed in the central lumen of the inner wall.
[0012] In another example, a method of using a heart valve delivery system is provided that includes inserting a delivery catheter through a central opening of a valve and an integral folded double-walled valve frame, releasably attaching a first retention assembly to an inner wall of the valve frame, releasably attaching a second retention assembly to an outer wall of the valve frame, tensioning the first retention assembly to collapse the inner wall of the valve frame onto the delivery catheter, and tensioning the second retention assembly to collapse the outer wall of the valve frame onto the inner wall of the valve frame. Collapsing the outer wall of the valve frame may comprise distally tensioning, stretching, or pulling the outer wall of the valve frame toward a distal end of the catheter. The method may further comprise sliding a delivery sheath of the delivery catheter over the folded valve.
[0013] In another example, a method for performing a mitral valve replacement procedure is provided, comprising: positioning a delivery device including a folded heart valve assembly in an orthogonal and centered orientation across the native mitral valve, where the heart valve assembly includes an integrated folded stent and attached valve leaflets, retracting a sheath of the delivery device to expose the folded heart valve, expanding an atrial end of the outer wall of the integrated folded stent in the left atrium, expanding a ventricular end of the outer wall of the integrated folded stent in the left ventricle, expanding an inner wall of the integrated folded stent, and releasing the integrated folded heart valve from the delivery device. The method may further comprise accessing the femoral vein, inserting a transseptal puncture device through the femoral vein to the right atrium, puncturing the intra-atrial septum, and inserting a delivery device with the folded heart valve assembly through the femoral vein to the left atrium. In some further examples, the expansion of the atrial end of the outer wall and the expansion of the ventricular end of the outer wall may occur at least partially simultaneously. The expansion of the atrial end of the outer wall and the expansion of the inner wall may occur at least partially simultaneously. The method may further include expanding the intra-atrial septum. Alternatively, the method may further include accessing the left thoracic cavity through the chest wall, puncturing the heart tissue at the apex of the left ventricle, and inserting the delivery device with the folded heart valve assembly transthoracically through the chest wall into the left ventricle. In the latter method, the open end of the integral folded stent may have a proximal end on the delivery device, whereas the transition end of the integral folded stent has a distal end on the delivery device. In yet another further embodiment, the method may further include accessing the femoral artery and inserting the delivery device with the folded heart valve assembly through the femoral artery and the aortic arch into the left ventricle.
[0014] In one embodiment, a replacement heart valve is provided that includes an integral stent frame, the stent frame having a collapsed configuration and an expanded configuration, and a tubular inner wall with a central lumen, the replacement heart valve including a replacement leaflet valve disposed in the central lumen of the inner wall, and a plurality of closed shapes attached to the stent frame, each of the plurality of closed shapes having an inner circumference surrounding a through opening. The plurality of closed shapes may include a plurality of rings. The plurality of rings are circular or elliptical rings. The plurality of closed shapes includes a plurality of closed wire shapes, each of the closed wire shapes including a wire segment welded end to end. The wire segment may include a wire diameter or a maximum wire cross-sectional dimension. The plurality of closed wire shapes may be attached to a plurality of stent frame openings, each of the plurality of stent frame openings having an opening diameter of 300% or less of the wire diameter or a maximum opening cross-sectional dimension of 300% or less of the maximum wire cross-sectional dimension. The aperture diameter may be no greater than 150% of the wire diameter, or the maximum aperture cross-sectional dimension may be no greater than 150% of the maximum wire cross-sectional dimension.
[0015] The stent frame may further comprise a plurality of longitudinal struts and a plurality of circumferential struts, with a plurality of stent frame apertures disposed within the longitudinal struts. The plurality of stent frame apertures may be disposed at ends of the longitudinal struts and / or spaced apart from the ends of the longitudinal struts. When the plurality of stent frame apertures are spaced apart from the ends of the longitudinal struts, the spacing distance may be greater than 300% of the aperture diameter or 300% of the maximum aperture cross-sectional dimension. The one-piece stent frame may comprise a folded double wall, with the stent frame further comprising an outer wall having an open expansion region, an intermediate reduced diameter region, and a closed expansion region, and a transition wall between the outer wall and the inner wall. The plurality of closed shapes attached to the stent frame may comprise a first plurality of closed shapes attached to the outer wall of the stent frame and / or a second plurality of closed shapes attached to the inner wall of the stent frame. The valve may comprise a delivery line slidably attached to each of the first and second plurality of closed stent shapes. The valve may further comprise a delivery line or loop slidably attached to the first plurality of closed stent configurations. The valve may further comprise a plurality of longitudinal slots disposed within the longitudinal struts, each of the plurality of longitudinal slots comprising an elongated barb projecting into each of the plurality of longitudinal slots. The valve may further comprise a plurality of pedicled hemispherical tabs projecting longitudinally from the stent frame. The replacement leaflet valve may comprise a tubular valve skirt attached to an inner wall of the stent frame and a plurality of leaflets having valve commissures therebetween, the plurality of leaflets being attached to the valve skirt, the tubular valve skirt comprising cutouts or openings located between the valve commissures.
[0016] In another variation, a replacement heart valve is provided that includes a one-piece stent frame, the stent frame having a collapsed configuration and an expanded configuration, a plurality of longitudinal struts and a plurality of circumferential struts, the plurality of longitudinal struts having a plurality of longitudinal slots, each of the plurality of longitudinal slots having an elongated barb projecting into each of the plurality of longitudinal slots, the stent frame having a tubular inner wall having a central lumen, and the replacement heart valve includes a replacement leaflet valve disposed in the central lumen of the first wall. The valve may further include a plurality of closed shapes attached to the stent frame, each of the plurality of closed shapes having an inner circumference surrounding the through opening. The plurality of closed shapes may include a plurality of rings. The plurality of rings may be circular or elliptical rings. The plurality of closed shapes includes a plurality of closed wire shapes, each of the closed wire shapes having wire segments welded end to end. The wire segments may include a wire diameter or a maximum wire cross-sectional dimension. The plurality of closed wire forms may be attached to a plurality of stent frame apertures, each of the plurality of stent frame apertures having an aperture diameter of 300% or less of the wire diameter or a maximum aperture cross-sectional dimension of 300% or less of the maximum wire cross-sectional dimension. The aperture diameter may be 150% or less of the wire diameter or the maximum aperture cross-sectional dimension may be 150% or less of the maximum wire cross-sectional dimension. The stent frame may further comprise a plurality of longitudinal struts and a plurality of directional struts, the plurality of stent frame apertures being disposed within the longitudinal struts. The plurality of stent frame apertures may be disposed at ends of the longitudinal struts and / or may be spaced apart from ends of the longitudinal struts. The plurality of stent frame apertures may be spaced apart from ends of the longitudinal struts by a distance greater than 300% of the aperture diameter or 300% of the maximum aperture cross-sectional dimension. The unitary stent frame may comprise a folded double wall, the stent frame further comprising an outer wall having an open expanding region, an intermediate reduced diameter region, and a closed expanding region, and a transition wall between the outer wall and the inner wall. The plurality of closed shapes attached to the stent frame may comprise a first plurality of closed shapes attached to the outer wall of the stent frame.The plurality of closed shapes attached to the stent frame may further comprise a second plurality of closed shapes attached to an inner wall of the stent frame. The valve may further comprise a delivery line or loop slidably attached to each of the first and second plurality of closed stent shapes. The valve may further comprise a delivery line slidably attached to the first plurality of closed stent shapes. The valve may further comprise a plurality of pedicled hemispherical tabs projecting longitudinally from the stent frame.
[0017] In another embodiment, a replacement heart valve is provided that includes a one-piece stent frame, the stent frame including a collapsed configuration and an expanded configuration and a tubular inner wall having a central lumen, the replacement heart valve including a replacement leaflet valve disposed in the central lumen of the inner wall, the replacement leaflet valve including a tubular valve skirt attached to the inner wall of the stent frame and a plurality of leaflets with valve commissures therebetween, the plurality of leaflets being attached to the valve skirt, the tubular valve skirt including cutouts or openings disposed between the valve commissures. The valve may include a plurality of closed shapes attached to the stent frame, each of the plurality of closed shapes including an inner circumference surrounding a through opening. The plurality of closed shapes includes a plurality of rings. The plurality of rings may include circular or elliptical rings. The plurality of closed shapes may include a plurality of closed wire shapes, each of the closed wire shapes including a wire segment welded end to end. The wire segments may include a wire diameter or a maximum wire cross-sectional dimension. The plurality of closed wire forms may be attached to a plurality of stent frame apertures, each of the plurality of stent frame apertures having an aperture diameter less than or equal to 300% of the wire diameter or a maximum aperture cross-sectional dimension less than or equal to 300% of the maximum wire cross-sectional dimension. The aperture diameter may be less than or equal to 150% of the wire diameter, or the maximum aperture cross-sectional dimension may be less than or equal to 150% of the maximum wire cross-sectional dimension. The stent frame may further comprise a plurality of longitudinal struts and a plurality of circumferential struts, the plurality of stent frame apertures being disposed within the longitudinal struts.
[0018] The plurality of stent frame apertures may be located at ends of the longitudinal struts and / or spaced apart from ends of the longitudinal struts. The plurality of stent frame apertures may be spaced apart from ends of the longitudinal struts by a distance greater than 300% of the aperture diameter or 300% of the maximum aperture cross-sectional dimension. The one-piece stent frame may comprise a folded double wall, the stent frame further comprising an outer wall having an open expansion region, an intermediate reduced diameter region, and a closed expansion region, and a transition wall between the outer wall and the inner wall. The plurality of closed shapes attached to the stent frame may comprise a first plurality of closed shapes attached to an outer wall of the stent frame. The plurality of closed shapes attached to the stent frame may further comprise a second plurality of closed shapes attached to an inner wall of the stent frame. [Brief description of the drawings]
[0019] [Figure 1A] FIG. 1A is a schematic side view of one embodiment of a heart valve stent. [Figure 1B] FIG. 1B is a schematic plan view of one embodiment of a heart valve stent. [Figure 1C] FIG. 1C is a partial cross-sectional view of the heart valve stent of FIG. 1A with a portion of the outer wall omitted. [Figure 1D] FIG. 1D is a schematic cross-sectional view of FIG. 1B. [Figure 1E] FIG. 1E is a schematic cross-sectional view of the inner wall of a heart valve stent excluding the outer wall. [Figure 1F] FIG. 1F is a schematic cross-sectional view of the outer wall of a heart valve stent excluding the inner wall, and FIG. 1F is a schematic cross-sectional view of FIG. 1B. [Figure 1G] FIG. 1G is a schematic diagram of two vertical struts of FIG. 1A. [Figure 1H] FIG. 1H is a schematic side view of a variation of a heart valve stent having a short outer wall. [Figure 2A] FIG. 2A shows a schematic of the cross-sectional configuration of struts in the outer wall of an exemplary folded stent structure. [Figure 2B]FIG. 2B illustrates a schematic cross-sectional configuration of struts on the inner wall of an exemplary folded stent structure. [Figure 3A] FIG. 3A illustrates a schematic cross-sectional configuration of struts in the outer wall of another exemplary folded stent structure. [Figure 3B] FIG. 3B illustrates a schematic cross-sectional configuration of struts on the inner wall of another exemplary folded stent structure. [Figure 4A] FIG. 4A shows various exemplary strut configurations. [Figure 4B] FIG. 4B illustrates various exemplary strut configurations. [Figure 4C] FIG. 4C illustrates various exemplary strut configurations. [Figure 5A] FIG. 5A is a schematic side view of another embodiment of a heart valve stent with attached leaflet valves and a skirt. [Figure 5B] FIG. 5B is a schematic bottom perspective view of the heart valve stent of FIG. 5A. [Figure 5C] FIG. 5C is a schematic top perspective view of the heart valve stent of FIG. 5A. [Figure 5D] FIG. 5D is a schematic top perspective view of a variation of the cuff structure of FIG. 5C. [Figure 6A] FIG. 6A is a top perspective view of a skirt structure for use with a heart valve stent. [Figure 6B] FIG. 6B is a top view of a skirt structure for use with a heart valve stent. [Figure 6C] FIG. 6C is a side view of a skirt structure for use with a heart valve stent. [Figure 6D] FIG. 6D is a cross-sectional view of the skirt structure of FIGS. 6A-6C. [Figure 7A] FIG. 7A is an atrial / superior view of the implanted heart valve. [Figure 7B] FIG. 7B is a ventricular / bottom view of the implanted heart valve. [Figure 8A] FIG. 8A is a schematic cross-sectional view of an exemplary diagram of a deployment procedure of a heart valve stent and delivery system. [Figure 8B] FIG. 8B is a schematic cross-sectional view of an exemplary diagram of a deployment procedure of a heart valve stent and delivery system. [Figure 8C] FIG. 8C is a schematic cross-sectional view of an exemplary illustration of a deployment procedure of a heart valve stent and delivery system. [Figure 8D] FIG. 8D is a schematic cross-sectional view of an exemplary diagram of a deployment procedure of a heart valve stent and delivery system. [Figure 8E] FIG. 8E is a schematic cross-sectional view of an exemplary diagram of a deployment procedure of a heart valve stent and delivery system. [Figure 9A] FIG. 9A shows various attachment rings positioned in the apertures of the stent structure. [Figure 9B] FIG. 9B shows various attachment rings positioned in the apertures of the stent structure. [Figure 9C] FIG. 9C shows various attachment rings positioned in the apertures of the stent structure. [Figure 10] FIG. 10 illustrates another exemplary attachment ring coupled to a stent structure. [Figure 11A] FIG. 11A is a schematic representation of a stent structure with the insertion barb in a flat position. [Figure 11B] FIG. 11A is a schematic representation of a stent structure with an insertion barb in an extended position. [Figure 11C] FIG. 11C is a side view of the barbed stent frame of FIGS. 11A and 11B. [Figure 11D] FIG. 11D is a schematic diagram of a modified example having mounting tabs. [Figure 12A] FIG. 12A shows another embodiment of a replacement valve and stent structure with radially oriented eyelets. [Figure 12B] FIG. 12B shows another embodiment of a replacement valve and stent structure with radially oriented eyelets. [Figure 13A] FIG. 13A shows another embodiment of a replacement valve and stent structure with partially rotated eyelets. [Figure 13B] FIG. 13B shows another embodiment of a replacement valve and stent structure with partially rotated eyelets. [Figure 14A] FIG. 14A shows an embodiment with eyelets and rings on the inner and outer walls. [Figure 14B] FIG. 14B shows an embodiment with eyelets and rings on the inner and outer walls. [Figure 15] FIG. 15 shows another variation of a replacement heart valve with an insertion barb, eyelets, and a valve skirt opening or cutout. DETAILED DESCRIPTION OF THE PREFERRED EMBODIMENTS
[0020] Embodiments herein are directed to a double-walled, folded stent structure having an inner wall that provides a tubular lumen for attachment to a leaflet valve assembly. The inner wall is configured to seal and / or secure to the surrounding native valve anatomy, but is spaced apart from a tubular outer wall that is continuous with the inner wall via a transition wall. The transition wall may result from folding, everting, or everting a single tubular structure into a double-walled, integral tubular stent frame or structure. The stent is configured to be reversibly collapsed to a reduced diameter or small cross-sectional shape for loading onto a catheter and delivery to a target anatomical site, and then re-expanded at the implantation site.
[0021] In further embodiments, the collapsed stent structure may be shaped with an intermediate region of reduced cross-sectional size of the outer wall, which allows for easy anchoring of the structure across a desired anatomical site. The intermediate region of reduced diameter or size is configured to expand against the native leaflets and / or anatomical opening, while the enlarged diameter or size of the end regions provides mechanical interference or resistance to displacement. The transition walls of the stent structure may be configured to promote fluid inflow into the lumen and through the replacement leaflets, while reducing turbulence and / or hemodynamic forces that displace or dislodge the valve. For example, the transition walls may be angled or tapered radially inward from the outer wall to the inner wall to improve flow or reduce peak forces acting on the transition walls, compared to transition walls oriented between the outer and inner walls, i.e., perpendicular to the longitudinal axis of the stent structure.
[0022] Although some of the exemplary embodiments described herein are directed to transcatheter replacement of the mitral valve, the components and structures herein are not limited to any particular valve or delivery method and may be adapted for implantation at the site of the tricuspid, pulmonary, aortic valve, as well as non-cardiac sites, such as the aorta, venous or cerebrospinal fluid systems, or native or artificial conduits, ducts, or shunts. As used herein, spatial references to a first or top end of a component may also be characterized by the anatomical space the component occupies and / or the relative direction of fluid flow. For example, the first or top end of a folded stent structure of a replacement mitral valve may be referred to as the atrial or upstream end of the valve, and the opposite end may be referred to as the ventricular or downstream end of the valve.
[0023] An exemplary embodiment of a stent structure 100 is shown in an expanded configuration in Figures 1A-1G. The stent structure 100 comprises an inner lumen 102 defined by an inner wall 104. An outer wall 106 is radially spaced from the inner wall 104 via a transition wall 108 to define an annular cavity 110. The stent structure 100 has a first closed end 112 located at the transition wall 108 and a second open end 114 of the outer wall 106 such that the annular cavity 110 is open and accessible.
[0024] The lumen 102 includes a first opening 116 surrounded by a transition wall 108 and a second opening 118 at a second open end 114 of the stent structure 100. The longitudinal axis 120, 320 of the lumen 102 typically coincides with the central axis of the stent structure 100, although in some variations the lumen may be eccentrically disposed relative to the outer wall of the stent structure. The lumen 102 typically includes a generally cylindrical circular cross-sectional shape between the first opening 116 and the second opening 118, as shown in Figures 1A-1D. In other examples, the lumen may include a frusto-conical, elliptical, or polygonal shape. In some variations, the stent structure may include a lumen in which the first and second openings differ in size and / or shape. The length of the lumen 102 may be within the range of 10 mm to 50 mm, 15 mm to 40 mm, or 20 mm to 25 mm, and the diameter or maximum cross-sectional dimension of the lumen along its longitudinal length may be within the range of 15 mm to 40 mm, 20 mm to 30 mm, or 25 mm to 30 mm. In embodiments in which the lumen has a non-cylindrical shape, the difference in diameter or cross-sectional dimension between the first opening 116 and the second opening 118 may be within the range of 1 mm to 10 mm, 1 mm to 5 mm, or 1 mm to 3 mm.
[0025] The location of the first and second openings 116, 118 of the lumen 102 relative to the overall stent structure 100 may vary. In some variations, the first opening 116 of the lumen 102 may be recessed relative to the first end 112, as depicted in FIGS. 1A-1G. In other examples, the first opening may be generally flush with the first end transition wall of the stent structure. The location of the first opening 116 may be characterized as recessed, flush, or protruding relative to the longitudinal position of the inner wall 104 or inner junction 122 between the lumen 102 and the transition wall 108, or the outer junction 124 between the transition wall 108 and the outer wall 106, as depicted in FIG. 1G. Similarly, the second opening 118 of the lumen 102 may be characterized as recessed, flush, or protruding relative to the longitudinal position of the outer opening 126 of the outer wall 106. For example, in the stent structure 100, the second opening 118 of the lumen 102 has an offset or protruding arrangement relative to the outer opening 126 of the outer wall 106. In some variations, the lumen may protrude relative to the second opening in the outer wall, in variations where a smaller or shorter outer wall is preferred to accommodate smaller sized native valve anatomy. However, the lumen size may remain relatively the same size among different size variations to provide consistent valve shape and / or hemodynamic properties.
[0026] The transition wall 108 of the stent structure 100 has a generally annular, slightly tapered shape surrounding the lumen 102 in the expanded configuration, but may have different shapes and / or surface angles in other variations. For example, with reference to FIG. 1G, the transition wall 108 in cross section may have a generally straight shape between the inner junction 122 and the outer junction 124, or in other variations may have a curved shape, e.g., a concave or convex shape. In other variations, the transition wall may have an angle that is generally perpendicular to the longitudinal axis of the lumen. Referring again to FIG. 1G, the transition wall 108 of the stent structure 100 may form an outer acute angle 128 with respect to the longitudinal axis 120 of the lumen 102. The angle 128 may be within the range of +45 degrees to +89 degrees, +75 degrees to +89 degrees, or +81 degrees to +85 degrees, or may vary anywhere within the range of ±1 degree, ±2 degrees, ±3 degrees, or ±4 degrees. In other variations, the transition wall angle may be within the range of -45 to +45 degrees, -75 to +75 degrees, or -85 to +85 degrees.
[0027] As previously mentioned, in some embodiments, the outer wall 106 of the stent structure 100 has a non-cylindrical shape when in the expanded configuration. The outer wall 106 may include a first end region 140 that is continuous with the transition wall 108 and has an outwardly convex shape, and a second end region 142 that forms the outer opening 126. As shown, the inner junction 122 between the upper region of the inner wall 104 and the transition wall 108 may have a first or upper inner radius of curvature R1 along the inner curvature of the curve and a first or upper inner bend angle A1. The bend angle is the angle defined by the arc length of the bend from the center of the radius of curvature between the point where the bend transitions to a straight segment or another bend. The outer junction 124 between the transition wall 308 and the upper region of the outer wall 106 may have a second or upper outer radius of curvature R2 and a second or upper outer bend angle A2. The middle region of the outer wall 108 may have a third or middle radius of curvature R3 and a third or middle bend angle A3, and the lower region of the outer wall 108 may have a fourth or lower radius of curvature R4 and a fourth or lower bend angle A4.
[0028] As shown in FIG. 1G, the center points of the first and second radii of curvature R1, R2 may be located within the annular cavity 110 of the stent 100, the third radius of curvature R3 may be located outside the outer wall 108, and the fourth radius of curvature R4 may be located within the ipsilateral annular cavity 110, the lumen 102, or the contralateral annular cavity 110b, depending on the size.
[0029] The radius of curvature and bend angle of the stent structure are not only used to define the shape of the stent in the expanded configuration, but also affect the shape of the stent in the delivery or collapsed configuration. A region or segment of the stent may be configured with a smaller radius of curvature and / or a larger bend angle to facilitate the folding of the stent at the region or segment when the stent is collapsed for the delivery or collapsed configuration. A larger radius of curvature or smaller bend angle may be provided to facilitate straightening of the region or segment for the delivery or collapsed configuration. For example, in the stent structure 100, a relatively small radius of curvature R1 allows the stent structure at the inner junction 122 to be easily folded or collapsed, while a larger radius of curvature R2 facilitates flattening of the first end region 140 during delivery or loading of the device into a delivery system. Thus, in the collapsed configuration, the transition wall 108 is further folded at the inner junction 122 and folded around the inner wall 104. Also, the outer wall 106 collapses around the inner wall 104 but not around the transition wall 108. Similarly, the intermediate region 142 and the second end region 144 of the outer wall 106 may also have larger radii of curvature R3 and R4, which flatten the concave shape of the intermediate region 142 and the convex shape of the second end region 144, making the outer wall 106 more collapsible. Thus, when the stent 100 is in the collapsed configuration, the inner wall 104 is radially inward relative to the outer wall 106 and the transition wall 108. The outer wall 106 and the transition wall 108 may contact the outer wall of a sheath, capsule, or delivery system, and the inner wall 104 may contact the inner core or catheter inner wall. In other embodiments, the stent structure may have a relatively large radius of curvature R1 and a relatively small radius of curvature R2 such that in the collapsed configuration, the transition wall collapses proximally relative to the delivery device and does not collapse relative to the inner wall 104, and the outer wall 106 collapses relative to both the inner wall 104 and the transition wall 108.
[0030] In some variations, the shape of the stent may be characterized by one or more relative characteristics of the stent in the expanded configuration. For example, the stent 100 may be characterized as A3 > A1 and A3 > A2 and A3 > A4 and / or R1 < R2 < R3 < R4, R1 < R2 ≈ R3 ≤ R4, R1 < R2 ≈ R3 ≈ R4, or R1 < R2 ≤ R3 ≤ R4.
[0031] Other variations of the stent may include the following. 1) R2 < R1 < R3 < R4 2) R2 < R1 ≈ R3 < R4 3) R2 < R1 ≈ R3 ≈ R4 4) R4 > R1 ≈ R2 5) R4 > R1 ≈ R2 > R3 6) The ratio of A2:A1 ranges from 1 to 3, 1.5 to 2.5, or 1.8 to 2.2 7) The ratio of A3:A4 ranges from 1 to 4, 1.5 to 3.0, or 2.2 to 2.4 8) The ratio of A2:A4 ranges from 2 to 4, 2.5 to 3.5, or 2.8 to 3.2
[0032] The stent structure herein further comprises a plurality of integrally formed stent strut segments as shown in Figures 1A-1G. Some struts may be generally characterized as longitudinal strut segments 130a, 130b, 130c that lie in a radial plane in which the longitudinal axis of the stent structure lies, or transverse strut segments 134a, 134b, 134c that are integrally formed with longitudinal struts 130a, 130b, 130c, 132a, 132b, 132c, where two longitudinal struts 130, 132 each lie in a different adjacent radial plane. In an embodiment having an even number of equally spaced longitudinal struts as depicted in Figure 1G, each radial plane 150 will include the longitudinal axis 120 of the stent structure 100 and two longitudinal struts 130, 136 located on either side of the stent structure 100. The longitudinal and transverse strut segments may be further grouped, with groups of longitudinal strut segments lying in the same radial plane to form continuous lengths of the transition wall 108 of the inner wall 104 and / or the longitudinal struts 130, 132 of the outer wall 106.
[0033] 1H shows another embodiment of a stent structure 150 similar to the stent structure 100, except that the outer wall 152 has a shorter longitudinal length, and therefore more inner wall 154 extends from the open end 156 of the outer wall 152, and the lateral struts 158 located at the open end 156 of the outer wall 152 are bent radially outward relative to the adjacent longitudinal struts 160. In some variations, the radial distance to where the center 162 of the lateral strut 158 would be if it were not displaced radially outward, e.g., a location 164 corresponding to the midpoint between the two nearest longitudinal struts 160a, 160b, ranges from 2 to 10 mm, or 3 to 8 mm, or 3 to 5 mm. This feature of increasing the radially outward position of the lateral struts may be provided in any of the other stent structure embodiments described herein.
[0034] In some instances, the longitudinal struts may have multiple continuous longitudinal strut segments, with the longitudinal struts in one wall terminating or interrupted at the junction of the adjacent wall, while in some embodiments they may span two or three walls. In some further embodiments, as shown for longitudinal struts 130, 152 in FIG. 1G, the longitudinal struts may be provided along the entire collapsed length of the stent structure, between the openings of the lumen, along the length of the inner wall, and through the transitions and the outer wall to the end of the outer wall, with each of the consecutive strut segments lying in the same radial plane 150. It is presumed that this arrangement of multiple continuous longitudinal struts throughout the collapsed stent structure provides structural integrity to the stent structure by better redistributing the forces acting on the stent structure and reducing the force concentrations found in stent structures having multiple parts that are welded or bonded together, whether during manufacture or use. In yet other examples, a continuous length of longitudinal struts may span all three walls, but the stent may include different strut configurations, e.g., differently oriented circumferential struts or tissue anchors, at one or both of the inner and outer ends of the collapsed stent structure.
[0035] In the exemplary stent structure 100, the longitudinal strut segments along the lumen of the stent structure 100 have a straight configuration such that the longitudinal strut segments are generally parallel in both the expanded and contracted configurations. Because of this arrangement, the lumen 102 does not exhibit any shortening when changing from the contracted configuration to the expanded configuration. This may reduce or eliminate axial stretching of the valvular structure attached to the lumen. This also allows the lumen to be predictably positioned and deployed while reducing the risk of unintended displacement.
[0036] The non-cylindrical configuration of the outer wall 106 may exhibit some shortening as the outer wall 106 transitions from a relatively straight orientation in the contracted configuration to a convex / concave / convex orientation in the expanded configuration. The shortening effect or displacement of the net displacement of the region of the stent structure from the contracted configuration to the expanded configuration may be controlled or limited by the change in orientation of the transition wall. The change in orientation of the transition wall displaces the outer wall 106 toward the open end of the stent structure 100, offsetting some of the other displacements of the outer wall such that the reduced diameter intermediate section of the outer wall is generally maintained in the contracted and expanded configurations. In some variations, the longitudinal displacement of the reduced diameter intermediate section of the outer wall with expansion of the stent structure may be less than 5 mm, less than 4 mm, less than 3 mm, less than 2 mm, or less than 1 mm.
[0037] The transverse strut segments may be characterized by a continuous set of transverse strut segments forming partial or complete circumferential or peripheral struts around the wall of the stent structure. However, the transverse strut segments may vary in other directions than just the circumferential direction. To facilitate expansion and contraction of the entire stent structure, one or more of the transverse strut segments, or all of the strut segments, may include a pair of angled legs, each transverse end of each angled leg being formed continuously or integrally with a longitudinal strut segment or strut, and each angled leg being joined at the center. The bend configuration formed by the two angled legs may have a simple bend, or in other examples, each leg may extend centrally to form a hairpin bend region.
[0038] The leg angles formed between each leg and the longitudinal struts may be different in different regions of the stent structure and may vary with leg length. In FIG. 4A, an exemplary configuration of transverse strut segments at the inner wall of the stent structure is shown. In an expanded configuration, the leg length of the inner wall is typically shorter than the leg length of the outer wall due to the relatively smaller radial expansion of the inner wall compared to the outer wall. Also, the legs of the inner wall may have a generally straight configuration since the limited radial expansion limits the structural strain that occurs at the leg angle. With reference to FIG. 4B and FIG. 4C, in other regions of the stent structure with a relatively larger radial expansion, such as the outer wall or potentially the transition wall, each leg may have a convex curvature along the acute leg angle and a concave curvature along the more acute leg angle closer to the intermediate bend region.
[0039] In some embodiments, the lateral strut segments of the inner wall may include acute leg angles less than 50 degrees, less than 45 degrees, or less than 40 degrees, or in the range of 30 to 50 degrees, 35 to 45 degrees, or 35 to 40 degrees, while the acute leg angles of the outer wall may be within the range of 30 to 75 degrees, 30 to 60 degrees, 35 to 55 degrees, or 40 to 50 degrees. The longitudinal spacing between longitudinally adjacent lateral strut segments in the lumen may be less than the longitudinal spacing in the outer wall, e.g., 2 to 8 mm, 3 to 7 mm, 4 to 6 mm, 2 to 6 mm, or 3 to 5 mm, 4 to 10 mm, 5 to 10 mm, 6 to 9 mm for the inner wall. This spacing is also the length of the longitudinal strut segments in the various wall regions.
[0040] With reference to FIG. 1G, the orientation of the legs and intermediate bends of one or more circumferential strut segments may be radially outwardly offset relative to adjacent longitudinal struts to provide a barbed or force concentrating structure to resist displacement of the strut structure relative to the native valve tissue. The transverse struts configured with barbs may be located anywhere along and / or around the outer wall of the stent structure, but in some variations may be located in the outer wall region 142, 144 between the reduced diameter region 142 and the outer opening 126 of the stent structure 100, or may be located toward the reduced diameter region 142. In some further examples, the radially outwardly offset circumferential struts may be provided on one or more circumferential struts closest to and pointing toward the smallest diameter region of the outer wall. In variations of valves used for mitral valve replacement, barbs may be formed on the struts to engage the lower annular tissue on the ventricular side. In some examples, all of the transverse strut segments of a circumferential strut are radially displaced, while in other examples, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, or any range between any two of these numbers, may be radially displaced, and every other transverse strut segment or the third or fourth transverse strut segment may be radially displaced. The degree of protrusion from the outer wall shape defined by the plurality of longitudinal struts may be within the range of 2 to 10 mm, 2 to 6 mm, or 2 to 4 mm. In some variations, the barb configuration may be characterized by the ratio of the radial distance between the tip of the barb and the longitudinal axis of the stent structure to the radial distance between the adjacent longitudinal strut or outer wall segment (excluding the barb) and the longitudinal axis of the stent structure. This ratio may be within the range of 1.1 to 1.5, 1.05 to 1.30, or 1.10 to 1.20.
[0041] As shown in FIG. 1G, the barb may comprise an extension of the transverse strut, and the extension may be located at the midline of the transverse strut. However, in other variations, the barb may be provided on the longitudinal strut or other struts of the stent frame. FIGS. 11A and 11B show, for example, a longitudinal barb 1114, which may be optionally adapted to any of the stent frame embodiments described herein. The barb 1114 is disposed within an elongated cavity or opening 1116 in the strut 1110. The barb 1114 may have a length in the range of about 1 mm to 10 mm, 2 mm to 8 mm, or 3 mm to 6 mm, and a width in the range of 0.05 mm to 3 mm, 0.1 mm to 1 mm, or 0.1 mm to 0.5 mm. The ends 1118 of the barb may be pointed or rounded. The orthogonal distance between the end 1118 of the barb 114 and the elongated opening 1116 may range from 1 mm to 10 mm, 2 mm to 8 mm, or 3 mm to 6 mm. The elongated cavity may have a length ranging from 3 mm to 15 mm, 4 mm to 12 mm, or 2 mm to 7 mm, and a width ranging from 1 mm to 4 mm, 1 mm to 3 mm, or 0.4 mm to 2 mm. The lateral gap between the side of the barb 1114 and the side of the opening 1116 may range from 0.05 mm to 2 mm, 0.1 mm to 1 mm, or 0.1 mm to 0.5 mm. The distal gap between the end 1118 of the barb 1114 and the opening 1116 may range from 0.05 mm to 2 mm, 0.1 mm to 1 mm, or 0.1 mm to 0.5 mm. The width of the strut 1110 may be wider in the segment or region in which the inserted barb 1114 and aperture 1116 are located than the width of the strut without the barb 1114 and aperture 1116. While the exemplary embodiment shown in Figures 11A and 11B is located at the end of the longitudinal strut 1110, at the junction between two transverse struts 1112, in other variations the barb 1114 may be located along the longitudinal strut 1110, at a junction spaced from the end of the longitudinal strut 1110, or at a location spaced from the junction where the transverse strut 1112 is located.FIG. 111C shows a stent structure 1120 with inserted barbs 1114 and elongated openings 1116 disposed on either end of longitudinal struts 1110 on an outer wall 1122 .
[0042] In some further examples, control apertures or attachment structures may be provided on the strut segments or at the junctions between two or more strut segments. The control apertures may be used to releasably attach tension members, including but not limited to sutures, wires, hooks, and the like, which may be relaxed or tightened to control the expansion, contraction, release, or loading of the stent structure during delivery of the valve prosthesis or during loading of the valve prosthesis into the delivery system. Various embodiments of delivery systems and methods are described in more detail below. Referring to the example of FIG. 1E, a control aperture is optionally provided at the junction of the ends of each of the consecutive longitudinal struts of the outer and inner walls. Additionally, a control aperture may be optionally provided at the intermediate bends of one or both of the two circumferential struts closest to the outer opening 126 of the outer wall 106.
[0043] In another variation shown in FIG. 11D, the end of the longitudinal strut 1110 includes an attachment head 1130 that protrudes from the end of the strut 1110 via an attachment neck 1132. The head 1130 and neck 1132 may be provided on one, two, three, four, five or more, or all, of the interior and / or exterior walls of the longitudinal struts of the stent frame. The head structure 1130 and neck structure 1132 may be used to hold or otherwise engage a delivery system, for example, when a rigid attachment is preferred over a tension line attachment. Here, the head structure 1130 has a hemispherical shape, but in other variations the head may be polygonal, square, rectangular, circular, oval, triangular, star-shaped, or other shapes. In the exemplary embodiment shown in FIG. 11D, the head and neck structures 1130, 1132 are provided on a strut 1110 that includes an inserted barb 1114 and a barb opening 1116, however, the two features need not be included together and the head and neck structures 1130, 1132 may be incorporated into any of the stent structures described herein.
[0044] 12A and 12B show another embodiment of a stent structure or replacement valve 1200 comprising an attachment structure having oval or circular eyelets 1202 provided via eyelet extensions or necks 1206 at the ends of longitudinal struts 1204 of the valve 1200, with the eyelets 1202 provided with circular openings 1208. In this exemplary embodiment, the eyelets 1202 are provided on the struts 1204 of the inner wall 1210, and a ring 1212 is attached to each eyelet 1202. The rings 1212 may be used to facilitate threading of the delivery line or loop 1214, as the radial inward / outward orientation of the openings 1208 of the eyelets 1202 may increase friction when the delivery line 1214 is pulled to facilitate collapse and / or loading of the valve 1200.
[0045] 13A and 13B show yet another embodiment of a stent structure or replacement valve 1300 comprising an attachment structure having a circular eyelet 1302 provided via an extension or neck 1306 at the end of a longitudinal strut 1304 of an inner wall 13010 of the valve 1300, and a circular opening 1308 in the eyelet 1302. However, this exemplary embodiment differs from the valve 1200 shown in FIGS. 12A and 12B in that the eyelet 1302 is rotated 30 to 45 degrees. This can be accomplished by twisting the neck 1306 of the eyelet 1302. This rotation reorients the eyelet openings 1308 partially circumferentially or tangentially and thus toward other adjacent eyelets, thereby reducing friction between the eyelets 1302 and the delivery line or loop 1314, so that attachment of a ring to each eyelet 1302 is not required or otherwise provided, as in the valve 1200 of Figures 12A and 12B. In other variations, the eyelet neck 1306 may be twisted in the range of about 15 to 90 degrees, or 30 to 60 degrees, although it is envisioned that larger twist angles may result in weakening of the eyelet neck. To increase the twist angle while minimizing loss of structural integrity, the number of smaller heating / deformation steps in the manufacturing process may be increased.
[0046] In the exemplary embodiment valves 1200, 1300 of Figures 12A-13B, the eyelets 1202, 1302 are disposed only on the inner walls 1210, 1310, respectively, of the valves 1200, 1300. However, in other variations, as shown in Figures 14A and 14B, a replacement valve and stent structure 1400 may include eyelets 1402, 1420 and rings 1404, 1424 disposed on both the inner wall 1410 and the outer wall 1422 of the valve 1400, or optionally only on the outer wall 1422. The eyelets 1420 and ring 1424 of the outer wall 1422 may be provided in the same range of variations and configurations as the eyelets 1202 and ring 1212 of the inner wall 1210 described above. In such an embodiment, a second or separate tension line or loop 1426 may be provided through the eyelets 1420 or rings 1424 of the outer wall 1422 relative to the loops 1414 of the inner wall 1410. However, in other embodiments, such as shown in FIG. 14B, a single loop 1430 may be provided that is threaded through the eyelets 1402, 1420 or rings 1404, 1424 of both the inner wall 1410 and the outer wall 1422. In this embodiment, the loop 1430 may or may not be threaded through all eyelets 1402, 1420 of the valve 1400. For example, in FIG. 14B, all eyelets 1420 of the outer wall 1422 of the valve 1400 are looped or threaded, while only one-third of the eyelets 1402 of the inner wall 1410 (four total) are looped. In such an embodiment, only three eyelets 1402 may be provided in the inner wall 1410. Thus, in such an embodiment, the valve 1400 may include only the eyelets that are used. In some variations, the number of outer wall eyelets provided may be the same as, less than, or more than the number of inner wall eyelets, as well as the number of outer wall eyelets looped in the delivery loop, relative to the number of inner wall eyelets.
[0047] 4A shows a schematic of one example of a strut configuration 400 disposed on a region or wall of a stent structure. The strut configuration 400 comprises longitudinal struts 402, 404 and transverse struts 406, 408. The longitudinal strut segments 402a, 404a and the transverse strut segments 406, 408 together form a closed perimeter of a stent opening or cell 410. For purposes of characterizing various geometric configurations of the strut configurations, longitudinal axes 410 and transverse axes 412 are described herein, although one of ordinary skill in the art will appreciate that other reference points or axes may be used. The longitudinal axis 410 is parallel to the longitudinal axis of the overall stent structure, and the transverse axis 412 is perpendicular to the longitudinal axis 412.
[0048] In the schematic strut configuration 400 shown in FIG. 4A, the longitudinal struts 402, 404 may be parallel or non-parallel depending on whether the lumen comprises a cylindrical or non-cylindrical, e.g., frusto-conical, shape. In variations where the longitudinal struts are non-parallel, the longitudinal struts 402, 404 have a small radial angle orientation, such as 1 to 5 degrees, 2 to 10 degrees, or 5 to 30 degrees, from the longitudinal axis of the stent structure to provide a frusto-conical shape. As shown in FIG. 4A, the longitudinal and transverse struts 402, 404, 406, 408 may comprise strut segments 402a, 402b, 404a, 404b, 406a, 406b, 408a, 408b. In some variations, the inner wall 104 of the stent structure 100 and the legs 406a, 406b, 408a, 408b of the lateral struts 406, 408 may have a generally straight or linear configuration, with deformation occurring primarily at the base 406c, 406d, 408c, 408d and bent regions 406e, 408e of each lateral strut 406, 408. In some variations where greater stiffness is desired, the lateral struts may be generally non-uniform along their length. This may be accomplished by making the relative width of the struts wider near the base and narrower in the middle of the struts. The acute angles 414a, 414b, 416a, 416b between the vertical struts 402, 404 and the legs 406a, 406b, 408a, 408b in this strut configuration 400 may range from 1 to 45 degrees, 10 to 40 degrees, or 20 to 35 degrees. In some variations, the intermediate region where the pair of legs are integrally formed may be configured with a simple angle or curved configuration, while in other variations, the curved region 406e, 408e may be configured with an acute angle configuration with a larger curvature 406f, 408f on the same side as the acute angle of the horizontal strut and a smaller curvature 406g, 408g on the obtuse angle side of the horizontal strut. The bending recess 408h of each bending region 406e, 408e has a vertical length and a horizontal width at the lesser curvature 406g, 408g. In some variations, these lengths and widths may be configured to aid in the distribution of forces as the stent structure contracts into a collapsed or delivery configuration.In some examples, the bend recess may have a longitudinal length in the range of 50 to 500 microns, 50 to 300 microns, or 50 to 250 microns, and a lateral width in the range of 50 to 500 microns, 50 to 350 microns, or 100 to 300 microns.
[0049] In some embodiments, the configuration of the lateral struts with respect to the orientation of the bend regions, and the relative configuration between the lateral and longitudinal struts, may vary. In the example strut configuration 400 of FIG. 4A, both bend regions "point" toward the transition end or otherwise toward the upstream end of the valve, but in other variations, the bend regions may be oriented relative to the legs of the lateral struts toward the open or downstream end of the valve.
[0050] 4B illustrates another exemplary embodiment of a stent configuration 430 comprising longitudinal struts 432, 434 and transverse struts 436, 438. The longitudinal strut segments 432a, 434a and transverse strut segments 436, 438 together form a closed perimeter of a stent aperture or cell 440. Here, the legs 436a, 436b, 438a, 438b of the transverse struts 436, 438 may have a curved or curvilinear configuration in the expanded configuration. The legs 436, 438 have a generally convex configuration at the bases 436c, 436d, 438c, 438d and a concave configuration at the bend regions 436e, 438e. In some variations, the convex / concave configuration may allow a larger amount of expansion from the delivery configuration to the expanded configuration and / or distribute more stress and strain along the entire length of the strut legs. The angles 444a, 444b, 446a, 446b between the longitudinal struts 432, 434 and the straight or intermediate portions 436i, 436j, 438i, 438j of each leg may be within the range of 25 to 135 degrees, 45 to 90 degrees, or 30 to 60 degrees. The bending regions may also include bending recesses 436h, 438h having a longitudinal length and a lateral width, which may be configured to adjust the force and force distribution of the stent in the delivery and expanded configurations. One or more bending regions 436e, 438e of each lateral strut 436, 438 may optionally include control apertures 436k, 438k, as described elsewhere herein. In FIG. 4B, the legs 436a, 436b, 438a, 438b and bend regions 436e, 438e face in the same direction, while in FIG. 4C, the legs 466a, 466b, 468a, 468b and bend regions 466e, 468e face in opposite directions.
[0051] Each strut segment or continuous length of longitudinal or transverse struts is configured with a transverse width or dimension, a radial height or dimension, and a cross-sectional shape. The shape may be generally polygonal, such as square, rectangular, trapezoidal, circular, or oval. The transverse width or dimension of each strut segment may be configured to provide different levels of radial force, with larger widths providing more force and smaller widths providing less force. In variations where the stent structure is formed by laser cutting a tubular base structure, the cross-sectional shape of the strut segments for the elongated length may comprise a segmented annular shape, as shown in Figures 2A-3B. In the specific exemplary embodiment of Figures 2A and 2B, struts 200a and 200b represent struts from the outer and inner walls of the stent structure, respectively. The inner wall struts 200b comprise a segmented annular shape having an outer convex curvature 202b furthest from the longitudinal axis of the stent structure and having a greater or greater curvature, an inner concave curvature 204b closer to the longitudinal axis of the stent structure and having a lesser or shorter curvature, and transverse surfaces 206b, 208b that are generally straight in cross section but have angular axes 210b, 212b generally perpendicular to the longitudinal axis of the stent structure. The outer wall struts 200a may initially be configured in the same or similar orientation as the inner wall struts 200b, but in embodiments where the outer wall is formed by eversion, the outer wall struts 200a will have an everted orientation relative to the longitudinal axis of the stent structure such that the outer curvature 202a is concave and of lesser curvature, while the inner curvature 204a closer to the longitudinal axis of the stent structure is convex and the greater curvature is concave. The transverse surfaces 206a, 208b have an offset angular orientation with respect to the longitudinal axis of the stent structure, e.g., the angular axes 210a, 210b of the transverse surfaces 206a, 208a do not intersect with the longitudinal axis of the stent structure. These configurations are notable in that they are located in different regions of the same longitudinal struts of the integral folded stent structure formed by the outer barb. The corresponding transition wall struts have a similar configuration in their expanded state as the outer wall struts 200a of the integral folded stent structure formed by the outer barb.
[0052] 3A and 3B show another embodiment of a folded stent structure having a series of configurations of outer and inner wall struts resulting from the inversion of a laser cut tube to form a lumen and inner wall, rather than the inversion configuration shown in FIG. 2A and 2B. In FIG. 3A and 3B, struts 300a and 300b represent struts from the outer and inner walls of the stent structure, respectively. The outer wall strut 300a comprises a segmented annular shape having an outer convex curvature 302a, which is furthest from the longitudinal axis of the stent structure and has a large or long curvature, and an inner concave curvature 304a, which is closer to the longitudinal axis of the stent structure and has a small or short curvature. The transverse surfaces 306a, 308a are generally straight in cross section, but have angular axes 310a, 312a that are generally oblique or non-intersecting with respect to the longitudinal axis of the stent structure. The inner wall struts 300b may initially have the same or similar orientation as the outer wall struts 300a, but in embodiments where the inner wall is formed by inversion, the inner wall struts 300b will have an inverted orientation such that the outer curvature 302b is concave and has a smaller curvature relative to the longitudinal axis of the stent structure, while the inner curvature 304b closer to the longitudinal axis of the stent structure is convex and has a larger curvature and is concave. The transverse surfaces 306b, 308b have an oblique or non-intersecting angular orientation relative to the longitudinal axis of the stent structure. Similar to the inversion configuration of the folded stent structure, these outer and inner wall configurations are located in different regions of the same longitudinal strut of the integral folded stent structure formed by inversion. The corresponding transition wall struts will have a similar configuration in the expanded state as the outer wall struts 200a of the integral folded stent structure formed by inversion. In some variations, the everting or inverting process may weaken or adversely affect portions of the stent structure compared to portions that do not undergo the everting or inverting process, such that radial forces generated on the outer wall of the stent structure may be greater in an inverted stent structure compared to an everted stent structure.
[0053] The edges of the polygonal struts may be rounded, smooth, or sharp. In FIGS. 2A and 2B, corners 214a-220b have clearly defined angled edges, while in FIGS. 3A and 3B, corners 314a-320b have rounded corners. The rounded corners and edges may be formed using mechanical polishing, chemical electropolishing, or a multi-step combination thereof (e.g., mechanical polishing followed by chemical polishing or electropolishing). In some variations, polishing may be performed prior to turning in or out of the laser cut tube. The dimensions and / or shape of the strut segments or struts may be uniform or may vary along their length. The radial thickness and / or circumferential width of the struts may be within the range of 300 to 500 microns, 360 to 460 microns, or 400 to 500 microns. The thickness and / or width of the struts may be uniform or non-uniform along the length of the strut segments. As previously mentioned, in some instances, the circumferential strut segments may be provided with a relatively larger width at their base and a relatively smaller width at the intermediate bend region.
[0054] The spacing between adjacent longitudinal or circumferential struts may be equal throughout the folded stent structure or may vary along the folded stent structure. For longitudinal struts, the number of struts may vary depending on the desired flexibility or radial expansion force desired for the stent structure, or based on the strut section width desired to achieve the desired radial expansion force or flexibility. For circumferential struts, there may be greater spacing in areas where greater radial expansion and / or less expansion force is desired, and less spacing in areas where less radial expansion and / or more expansion force is desired.
[0055] The various stent structures described herein may include one or more of the following features. 1) The net longitudinal stent length (i.e., the maximum distance spanned by the stent along the longitudinal axis) is in the range of 15 to 60 mm, 20 to 40 mm, or 25 to 35 mm. 2) The folded longitudinal stent length (e.g., the longitudinal length of the continuous longitudinal struts from end to end when completely straightened) is in the range of 40 to 100 mm, 50 to 90 mm, or 60 to 80 mm. 3) the maximum stent diameter or transverse dimension in the expanded configuration is in the range of 20 to 80 mm, 30 to 60 mm, or 45 to 55 mm. 4) The maximum outer end diameter or lateral dimension in the expanded configuration is in the range of 25 to 75 mm, 35 to 65 mm, or 48 to 58 mm. 5) the maximum transition end diameter or maximum transition end transverse dimension in the expanded configuration is in the range of 20 to 80 mm, 25 to 55 mm, or 40 to 50 mm, optionally 0 to 20 mm, 1 to 15 mm, 2 to 10 mm, 2 to 8 mm, or 2 to 5 mm less than the maximum outer end diameter or maximum stent diameter or transverse dimension; 6) Lumen length is in the range of 10 to 50 mm, 15 to 40 mm, or 20 to 26 mm. 7) The lumen diameter or maximum cross-sectional dimension is in the range of 10 to 40 mm, 15 to 35 mm, or 26 to 31 mm. 8) The medial upper radius of curvature R1 is in the range of 1 to 10 mm, 2 to 8 mm, or 3 to 5 mm. 9) The medial upper bend angle is in the range of 0 to 180 degrees, 60 to 135 degrees, or 75 to 90 degrees, or is 83 degrees. 10) The transition wall outboard angle relative to the longitudinal axis of the stent structure is in the range of 0 to 180 degrees, 45 to 100 degrees, 75 to 90 degrees, or is 90 degrees. 11) The transition wall radial width is in the range of 5 to 30 mm, 5 to 20 mm, or 5 to 10 mm. 12) The outer upper radius of curvature R2 is in the range of 0.5 to 6 mm, 1.5 to 5 mm, or 2.5 to 4 mm. 13) The outer upper bend angle A2 is in the range of 45 to 270 degrees, 90 to 235 degrees, 135 to 200 degrees, or 160 to 200 degrees. 14) The exterior wall longitudinal length is in the range of 10 to 40 mm, 20 to 35 mm, or 25 to 30 mm. 15) The length of the exterior wall curve is in the range of 10 to 50 mm, 20 to 50 mm, or 30 to 40 mm. 16) The exterior wall longitudinal strut length from the exterior edge to the transition wall is in the range of 12 to 50 mm, 20 to 40 mm, or 25 to 35 mm. 17) The radius of curvature of the outer wall mid-region is in the range of 1 to 15 mm, 3 to 12 mm, 4 to 8 mm, or 3 to 6 mm. 18) The exterior wall mid-region bend angle is in the range of 10 to 180 degrees, 30 to 160 degrees, 60 to 160 degrees, or 80 to 140 degrees. 19) The radius of curvature R4 of the outer wall open end region or lower region is in the range of 5 to 100 mm, 5 to 40 mm, or 10 to 20 mm. 20) The exterior wall open end region or lower region bending angle A4 is in the range of 1 to 90 degrees, 10 to 90 degrees, 20 to 80 degrees, or 30 to 70 degrees. 21) The maximum radial difference between the minimum and maximum radii in the same radial plane of the outer wall of the stent structure is in the range of about 6 to 15 mm, 8 to 12 mm, 9 to 11 mm, or is about 10 mm. 22) The outer wall first edge / atrium / upper region maximum radius is in the range of 20 to 30 mm, 22 to 28 mm, or 24 to 27 mm. 23) The mid-area minimum radius of the exterior wall is in the range of 10 to 30 mm, 12 to 25 mm, or 15 to 20 mm. 24) The second edge of the outer wall / ventricle / inferior region maximum radius is in the range of 20 to 35 mm, 25 to 30 mm, or 26 to 29 mm. 25) The ratio of longitudinal length to diameter is in the range of 0.40 to 1.0, 0.45 to 0.80, or 0.50 to 0.60. 26) The number of longitudinal struts is divisible by 3, e.g., selected from the group consisting of one or more of 3, 6, 9, 12, 15 longitudinal struts. 27) The ratio between the radial distance between the barb tips and the longitudinal axis of the stent structure and the radial distance between adjacent longitudinal struts or outer wall segments (excluding barbs) and the longitudinal axis of the stent structure is in the range of 1.1 to 1.5, 1.05 to 1.30, 1.05 to 1.20, or 1.05 to 1.15. 28) The medial opening position relative to the lateral opening position along the longitudinal axis is positive (i.e., protruding from the lateral opening), neutral (i.e., flush with the lateral opening), negative (i.e., recessed from the lateral opening), and / or in the ranges of -4 to -12 mm, -5 to -10 mm, -6 to -9 mm, +1 to +8 mm, +2 to +6 mm, +3 to +5 mm, -3 to +3 mm, +0 to +3 mm, -12 to +5 mm, -6 to +6 mm, or -7 to +4 mm.
[0056] The scope of the stent structures described herein need not be limited to require the selection of each of the above characteristics, and single characteristics or subsets of characteristics are contemplated. For example, in some variations, the stent structure may or may not include valves and / or skirting, and may be of the following structure: 1) A folded, one-piece stent structure having an everted outer wall strut configuration or an everted inner wall strut configuration. 2) A folded monolithic stent structure, the number of longitudinal struts being divisible by 3, the lumen being non-shortened, the outer wall being optionally foreshortened, the radial strut thickness being in the range of 400 to 450 microns, and the longitudinal length to diameter ratio being in the range of 0.50 to 0.60. 3) A folded monolithic stent structure having an upper inner radius of curvature smaller than an upper outer radius of curvature, a lumen extending from an outer opening in the outer wall between 0 and 3 mm, and a barb-to-outer wall radius ratio in the range of 1.1 to 1.2. 4) A folded, dual-walled, integral stent structure having 12 longitudinal struts and 3 to 5 circumferential struts in the inner lumen, 1 to 2 circumferential struts in the transition wall, and 3 to 5 circumferential struts in the outer wall.
[0057] In the embodiment shown in Figures 1A-1G, the stent structure 100 comprises a plurality of end-to-end longitudinal struts and a plurality of circumferential transverse struts, each in turn comprising a successive set of continuous longitudinal or transverse strut segments. In a particular example of the stent structure 100, twelve evenly spaced end-to-end longitudinal struts are provided, with nine complete sets of circumferential struts along the folded stent structure 100. Four sets of closely spaced circumferential struts are provided along the inner wall, with legs that are relatively straight or minimally curved, with an intermediate bend directed toward the upper or closed end of the stent structure. The transition wall 108 comprises a set of circumferential struts with a relatively increased base curvature in each leg and a relatively decreased curvature around an intermediate bend that is directed radially outward toward the outer wall 106. The outer wall 106 includes four sets of circumferential struts with their intermediate bends directed toward the closed end of the stent structure 100, except for the set of circumferential struts closest to the opening in the outer wall 106, which may be directed toward the open end of the stent structure 100. The orientation of the legs and intermediate bends of the third set of circumferential struts are offset radially outward relative to the adjacent longitudinal struts to provide a barbed or force concentrating structure that resists displacement of the strut structure against the native valve tissue. Typically, these radially outwardly displaced circumferential struts are closest to the portion of the outer wall between the narrowest diameter and the downstream or open end of the stent structure, as shown in Figures 1A and 1C, and may be provided on one or more circumferential struts that are directed toward the narrowest diameter or inlet / upstream end of the stent structure.
[0058] As previously mentioned, controlled openings are provided at the outer end or at the junctions between the longitudinal and circumferential struts at the outer end, and at the inner end or at the junctions between the longitudinal and circumferential struts at the inner end, and in the lumen of the stent structure 100. Control openings are also provided in the intermediate bends of the two circumferential struts closest to the outer end of the stent structure 100.
[0059] For the stent structure 100, the net longitudinal stent length may be 25 to 35 mm, the collapsed longitudinal stent length may be 60 to 90 mm, the maximum stent diameter or transverse dimension in the expanded configuration may be 45 to 55 mm, the maximum outer end diameter or transverse dimension in the expanded configuration may be 45 to 55 mm, the maximum transition end diameter or transverse dimension in the expanded configuration may be 40 to 50 mm, which may be 1 to 5 mm less than the maximum outer end diameter or maximum stent diameter or transverse dimension, the lumen length may be 20 to 25 mm, the lumen diameter or maximum cross-sectional dimension may be 20 to 30 mm, the inner upper radius of curvature may be 3 to 5 mm, the inner upper bend angle may be 90 to 105 degrees, the transition wall outer angle relative to the longitudinal axis of the stent structure may be 75 to 90 degrees, the transition wall radial width may be 15 to 20 mm, and the outer upper radius of curvature may be 20 to 25 mm. The outer wall open end region or lower region curvature radius may be in the range of 1 to 4 mm, the outer upper bend angle may be 160 to 200 degrees, the outer wall longitudinal length may be 20 to 25 mm, the outer wall curve length may be 25 to 40 mm, the outer wall longitudinal strut length from the outer end to the transition wall may be 25 to 35 mm, the outer wall mid-region curvature radius may be 3 to 6 mm, the outer wall mid-region bend angle may be 60 to 120 degrees, and the outer wall open end region or lower region bend angle may be 160 to 200 degrees. The curvature radius may be 10 to 50 mm, 10 to 30 mm, or 10 to 20 mm, the outer wall open end region or lower region bend angle may be 20 to 135 degrees, 30 to 90 degrees, or 50 to 70 degrees, the maximum radius difference between the minimum and maximum radii in the same radial plane of the stent structure may be 9 to 11 mm, and / or the negative of the inner opening position relative to the outer opening position along the longitudinal axis may be -6 to -9 mm.
[0060] 1A-1F, the stent structure 100 includes twelve consecutive longitudinal struts and nine circumferential struts, similar to stent structure 100. Stent structure 100 includes four circumferential struts along lumen 102, but other variations may include two, three, five, or six circumferential struts in the lumen. The orientation of the circumferential struts of the inner wall 104 is oriented toward the closed end of the stent structure 100, while the circumferential struts of the transition wall 108 are oriented radially outward, but in some variations, one or more circumferential struts, e.g., the circumferential strut closest to the open end of the outer wall, are oriented radially inward and / or toward the open end of the stent structure. Any other variation may include a transition wall that has an orthogonal orientation to the longitudinal axis, while the transition wall 108 of stent structure 100 is slightly or substantially angled. It is speculated that the inwardly sloping transition wall may reduce turbulent or non-laminar flow into the lumen opening or peak axial forces that may displace the stent structure from the target location during atrial contraction.
[0061] In some embodiments described herein, the upper or transition end of the stent structure is configured to be used as the upstream end of a replacement valve, and blood flow is received at the transition end of the lumen and passes through the valve structure attached to the lumen. The valve structure may be any of a variety of valve structures, including a flap valve, a ball-in-cage valve, or a leaflet valve. The leaflet valve material may comprise autologous, allogeneic, or xenogeneic materials, or artificial materials, e.g., biomaterials derived from natural materials or anatomical structures such as porcine, bovine, or equine pericardial tissue or valves, or the patient's own cells, and may be fixed with any of a variety of chemicals, such as glutaraldehyde, to reduce antigenicity of the valve and / or to alter the physiological and / or mechanical properties of the valve material. If a leaflet valve is provided, the leaflet valve may be a bi-leaflet valve structure or a tri-leaflet valve structure. The commissures of the valve may be attached or sutured to the longitudinal and / or circumferential struts of the lumen, for example every fourth longitudinal strut of a stent structure 100 comprising a tri-leaflet valve.
[0062] The replacement valve may further comprise one or more skirt materials in one or more regions of the stent structure. The skirt material may be comprised of a stiff, tightly woven or loosely woven sheet of autologous, allogeneic or xenogeneic or artificial material that may be the same or different from the leaflet material of the valve. The skirt material may comprise polytetrafluoroethylene (PTFE), polyester, polyethylene terephthalate (PET) material. In variations comprising an open pore material, the average pore size may be in the size range of about 0.035 mm to 0.16 mm, or 0.05 mm to 0.10 mm, or 0.07 mm to 0.09 mm. The open pore material may provide greater elasticity or flexibility in areas of the stent structure that experience greater configurational changes. Other areas of the stent that do not require elasticity or flexibility may be provided with a stiff sheet material without pores. The skirt material may comprise a single or multi-layer structure and may comprise one or more coatings to modulate thrombosis, tissue ingrowth, and / or lubricity.
[0063] 5A-5C show an example of a replacement valve 500 having a skirt 502 comprising two different materials attached to a stent structure 504. In this particular embodiment, a stiff or packed woven material is provided around the outer and inner surfaces of the downstream or lower region 508 of the outer wall 510 as a cuff structure 506. The outer surface of the inner wall 512 is provided with the same or different cuff structure of stiff or packed woven material. FIG. 5C shows a variation using a different material for the inner wall 512, and FIG. 5D shows another variation having the same cuff structure spanning the annular cavity 522 and covering the outer surface of the inner wall 512. A porous knit material is used for the upper region 516 of the outer wall 510, the transition wall 518, and another cuff structure 514 around the upstream opening 520 of the inner wall 512 of the stent structure 504. An artificial or animal-derived material may be used to form the valve pocket and the leaflets 516a-c located in the lumen 512. In addition to providing elasticity for expansion as the stent structure expands, the porous knit material may also provide for cell migration and tissue engraftment to the replacement valve. This dual material skirt 502 allows blood entering the annular cavity 522 to pass through the porous material of the cuff structure 514, but the porous material may have a porosity that is small enough to resist the passage of thrombus that may form.
[0064] In another variation shown in Figures 6A-6D, the skirt 600 comprises a tubular material. Such a shape of the skirt 600 may allow for a more consistent attachment of the skirt 600 to the stent structure, reducing potential problems with excess sheet material in narrow stent regions. In this particular variation, the skirt 600 comprises an interior central cavity 602 formed by an interior wall 604 and an interior annular cavity 606 between the interior wall 604 and a shaped exterior wall 608. The exterior wall 606 may be formed in a configuration complementary to the exterior wall of the stent structure, such as an enlarged upstream region 610, a reduced diameter intermediate region 612, and an enlarged diameter downstream region 614. The skirt 600 is disposed on the closed end of the stent structure such that the stent structure is located within the annular cavity 606 and the interior wall 604 of the skirt 600 is located within the lumen of the stent structure. In some variations, the interior wall 604 may be inverted into the lumen of the stent structure. A tapered annular skirt 616 may be provided to span the annular cavity 606 between the inner wall 604 and the molded outer wall 608. The outer wall 608 of the skirt 602 may comprise a porous or woven material that is heat set into an expanded configuration and may span the entire outer wall 606, the transition wall 618 of the skirt 602, and optionally a portion of the inner wall 606, where it is sewn, glued, and / or welded to a tubular solid woven material configured to line the lumen of the stent structure. The tapered annular skirt 616 may be sewn, glued, welded, or otherwise attached to the inner surface of the outer wall 606 and the outer surface of the inner wall 604 after the outer wall 606 and inner wall 604 are initially assembled into the stent structure. Similarly, the leaflet structure may be sewn, glued, welded, or otherwise attached to the inner wall 604 of the skirt 600 after the inner wall 604 is inserted into the lumen of the stent structure.
[0065] The skirt material may be sutured to the exterior and / or interior surfaces of the inner, transition, and / or outer walls of the stent, or in some variations may be provided as a cuff or folded structure over the outer end, inner end, or transition wall of the stent structure, e.g., covering the interior surface of the outer wall, the interior surface of the transition wall, and the exterior surface of the inner wall, spanning the interior and exterior surfaces of the stent walls, or transitioning from the interior or exterior surface of one wall to another, e.g., lining the annular cavity of a replacement valve.
[0066] FIG. 15 illustrates another exemplary embodiment of a replacement valve 1500 comprising a stent frame 1502 and a valve assembly 1504. For illustrative purposes, the leaflets have been omitted from the figure so that only the inner 1506 and outer 1508 valve skirts of the valve assembly 1504 are shown. In this embodiment, the inner skirt 1506 lining the inner wall 1510 and / or the outer skirt 1508 covering the outer surface of the outer wall 1512 comprise a polymeric material as previously disclosed, which may be a knitted or woven fabric including PET or a PET / ultra-high molecular weight polyethylene hybrid material. In some variations, a woven material may be used if one wishes to reduce porosity or use a sealing material, and a knitted material may be used if one wishes to increase porosity or encourage tissue in-growth. In the particular embodiment shown, the inner skirt 1506 further comprises one or more cutouts or openings 1514 located between the valve commissures. It is presumed that backflow into the open end of the valve 1500 may fill the annular cavity 1516 between the inner wall 1510 and the outer wall 1512 of the valve 1500 and may be directed through the skirt openings 1514 toward the leaflets (not shown). Increasing flow toward the leaflets may improve the force and velocity of valve closure, improving leaflet kinematics and valve hemodynamics. This particular embodiment is shown with an exemplary insertion barb 1518 and eyelets 1520, 1522, as described elsewhere herein, although the eyelets 1520, 1522 are shown without rings for ease of illustration.
[0067] 7A and 7B are photographs of an exemplary replacement valve 700 having a dual material skirt as described with respect to Figures 5A and 5B above, used in mitral valve animal testing, explanted after 30 days. The atrial side of the valve 700 shown in Figure 7A showed tissue or cell ingrowth into the large pore knit fabric 702, with good ingrowth at the border or junction of the large pore knit fabric 702 and the dense fabric, while the ventricular side of the valve 700, which is covered primarily by the small pore dense fabric 704 around the outer and inner openings 706, 708, showed good tissue ingrowth.
[0068] manufacturing In some variations, the stent structure may be manufactured using a superelastic Nitinol tube with various slits or slots laser cut to achieve an initial tubular stent shape. Then, in a series of repeated deformation, heating, and cooling steps, the tubular stent is gradually expanded to at least the initial size of the lumen of the stent structure. Next, the portions of the stent structure corresponding to the transition wall and the outer wall are gradually expanded further to a desired diameter, followed by gradually everting to form the outer wall using a mandrel, and gradually reducing the middle region of the outer wall, or further expanding the upstream and downstream end regions of the outer wall, to achieve a reduced diameter shape of the outer wall. In another step, one or more bend regions on the lateral struts are displaced radially outward around the middle region to form a retaining barb or structure.
[0069] In another embodiment, after the tube is initially cut, the tube may undergo a series of repeated deformation, heating, and cooling steps to be incrementally expanded to at least the initial size of the outer lumen of the stent structure, after which portions of the stent structure corresponding to the transition and inner walls are inverted into the outer wall to form a closed end and inner wall. The outer wall may be further expanded or incrementally adjusted to a desired shape, for example, by further expanding the open and closed end regions of the outer wall, or by reducing the cross-sectional size or diameter of the intermediate region. One or more bend regions on the lateral struts around the intermediate region may be displaced radially outward to form retention barbs or structures.
[0070] Valve Loading and Delivery As previously mentioned, the stent structure may be provided with a number of control openings which may be used to attach one or more sutures to control expansion and contraction in different regions on the stent structure and / or one or more hooks to releasably hold the stent structure until final placement at the treatment site. In other examples, instead of using control openings, sutures or wraps may be provided on the exterior of one or more regions of the stent structure.
[0071] In some instances, the sutures may be tensioned or clamped to collapse the outer and inner walls of the stent structure for loading into the delivery catheter. The sutures may be manipulated to collapse the inner wall before the outer wall, or both may be collapsed simultaneously. Similarly, one end of the inner or outer wall may be collapsed first, or both ends of the inner or outer wall may be collapsed simultaneously. This may be done at room temperature, or in a sterile cold water bath or a sterile ice water bath at the time of use or manufacture. After collapse, the sheath may be extended distally beyond the distal catheter portion where the replacement valve resides. The valve may be rinsed with sterile saline prior to loading to remove any preservatives remaining on the valve.
[0072] In some variations, the transition wall of the stent structure is folded at the inner junction so that in the collapsed configuration the transition wall is positioned directly over the delivery catheter or tool like the inner wall, while in other examples, the outer wall is pulled distally during collapse and loading, deploying the transition wall at the outer junction so that the transition wall is positioned radially outward from the inner wall when contracted to the collapsed configuration.
[0073] The retention sutures of the delivery system may be controlled proximally by the user using a pull ring, slide lever, and / or a rotating knob, which are further configured to be locked in place except during movement via a bias spring or mechanical mating locking configuration as known in the art. The proximal end of the delivery system may be robotically controlled using any of a variety of robotic catheter guidance systems known in the art. The sutures may slide along one or more lumens of the delivery catheter in addition to the flush lumen, guidewire lumen, steering wire lumen, including rapid exchange guidewire configurations. The sutures may exit at different locations around the distal region of the delivery catheter or may exit the distal region of the catheter through multiple openings. The multiple openings may be circumferentially spaced and / or longitudinally spaced around the catheter body depending on the area of the stent structure controlled by the sutures.
[0074] In one exemplary method of delivering a replacement valve, the patient is positioned on a procedure table, draped and sterilized in the usual manner. Anesthesia or sedation is administered. Percutaneous or open access to the femoral vein is obtained and an introduction guidewire is inserted. The guidewire is manipulated to reach the right atrium and a Brockenbrough needle is positioned and used to puncture the atrial space to reach the left atrium. Alternatively, image guidance may be used to detect whether patent ovale septum access or residual access is available and the guidewire may be threaded through an existing anatomical opening. A balloon catheter may be used as needed to enlarge the opening in the intraatrial septum. An electrocautery catheter may be used to create an opening in the intraatrial septum. Once in the left atrium, the guidewire is introduced through the mitral valve and into the left ventricle. A preformed guidance catheter or a balloon catheter may be used to facilitate crossing of the mitral valve. Once in the left ventricle, a delivery catheter loaded with a replacement valve is inserted over the guidewire.
[0075] 8A, a delivery system 800 having a delivery catheter 802 and a valve 804 is positioned across a mitral valve opening 806. The delivery system 800 may be further manipulated to adjust the angle of entry through the mitral valve opening 806 to be approximately perpendicular to the native valve opening and / or centered with the mitral valve opening 806. Once the desired catheter position is achieved, the delivery sheath 808 is withdrawn proximally, exposing the collapsed valve 804.
[0076] In Figure 8B, one set of sutures controlling the release of the downstream or ventricular end 810 of the outer wall 812 of the valve 804 is partially released while the tensioning member controlling the inner wall 816 remains in tension. Then, in Figure 8C, the ventricular end 810 of the outer wall 812 of the valve 804 is further released, allowing more of the ventricular end, mid-region, and atrial end 814 of the outer wall 812 to expand further, thereby allowing the transition wall 816 of the valve 802 to expand at least partially outward. The partial expansion of the atrial end 814 and ventricular end 810 of the valve 802 serves to further center and orthogonally orient the mid-region 822 of the valve 802 prior to full release. The initial expansion of the atrial end 814 of the outer wall 812 in this embodiment is a by-effect of the partial release of the ventricular end 810 of the valve 802 as longitudinal tension is released, although in other examples independent tension member control of the atrial end 814 may be provided.
[0077] In FIG. 8D, the tension members at the ventricular end 810 and the atrial end 814 are further released, either simultaneously or stepwise alone, to further engage the intermediate region 820 of the outer wall 812 against the valve opening 806. This further expansion of the outer wall 812 exposes the retention barbs or projections 822 on the outer wall 812. Proper centering and orientation of the valve is reconfirmed to ensure that the valve is not deployed tilted or partially dislodged from the mitral valve annulus. In some variations, the tension members may be re-tensioned to re-collapse the valve 804 to facilitate repositioning and / or reorienting the valve 804. Once confirmed, the tension members at the inner wall 818 are released, allowing the outer wall 812 to expand unconstrained against the mitral valve opening 806, as shown in FIG. 8E. The tension members may then be cut or otherwise released or separated from the valve, and the tension members may be withdrawn into the catheter, and optionally from the proximal end of the catheter. The delivery catheter and guidewire can then be withdrawn from the patient and hemostasis is achieved at the femoral vein site.
[0078] In yet another exemplary method of delivering a replacement valve, the patient is positioned on a procedure table and draped and sterilized in the usual manner. Anesthesia or sedation is administered. Percutaneous or cut-down access to a vessel or access site, such as the femoral vein, femoral artery, radial artery, or subclavian artery, is obtained and an introducer guidewire is inserted. The guidewire is manipulated to reach the intended valve implantation site. A pre-shaped guidance catheter or balloon catheter may be used to facilitate crossing of the valve implantation site.
[0079] 8A, a delivery system 800 having a delivery catheter 802 and a valve 804 is positioned across a valve opening 806. The delivery system 800 may be further manipulated to adjust the angle of entry through the valve opening 806 to be approximately perpendicular to the native valve opening and / or centered with the valve opening 806. Once the desired catheter position is achieved, the delivery sheath 808 is retracted proximally, exposing the collapsed valve 804.
[0080] In FIG. 8B, one set of tensioning members controlling the release of the downstream end 810 of the outer wall 812 of the valve 804 is partially released, while the tensioning members controlling the inner wall 816 remain in tension. Then, in FIG. 8C, the downstream end 810 of the outer wall 812 of the valve 804 is further released, allowing more of the downstream end, middle region, and upstream end 814 of the outer wall 812 to expand further, thereby allowing the transition wall 816 of the valve 802 to at least partially expand outward. The partial expansion of the atrial end 814 and ventricular end 810 of the valve 802 serves to further center and orthogonally orient the middle region 822 of the valve 802 before full release. While the initial expansion of the atrial end 814 of the outer wall 812 in this embodiment is a by-effect of the partial release of the ventricular end 810 of the valve 802 as longitudinal tension is released, in other examples, independent tensioning member control of the upstream end 814 may be provided.
[0081] In FIG. 8D, the tensioning members at the downstream end 810 and the upstream end 814 are further released, either simultaneously or stepwise alone, to further engage the intermediate region 820 of the outer wall 812 against the valve opening 806. This further expansion of the outer wall 812 exposes the retention barbs or projections 822 on the outer wall 812. Proper centering and orientation of the valve is rechecked to ensure that the valve is not deployed tilted or partially dislodged from the valve annulus. The tensioning members may be optionally re-tensioned to re-collapse the valve 804 to facilitate repositioning and / or reorienting the valve 804. Once confirmed, the tensioning members at the inner wall 818 are released, allowing the outer wall 812 to also expand unconstrained against the mitral valve opening 806, as shown in FIG. 8E. The tensioning members may then be separated from the valve 804 and withdrawn into the catheter, and optionally from the proximal end of the catheter 802.
[0082] In yet another exemplary method of delivering a replacement valve, the patient is positioned on the procedure table and draped and sterilized in the usual manner. Anesthesia or sedation is administered, and selective ventilation of the right lung and possibly the left upper lobe is performed to allow controlled collapse of the left lower lobe. A purse string suture is placed at the transscapular or other cardiac entry site. A trocar is inserted through the proximal hemostatic valved cannula or introducer, and a trocar assembly is inserted through the purse string suture to access the ventricle and target valve.
[0083] 8A, a delivery system 800 comprising a delivery rigid tool 802 and a valve 804 is positioned across a valve opening 806. The delivery system 800 may be further manipulated to adjust the angle of entry through the valve opening 806 to be approximately perpendicular to the native valve opening and / or centered with the valve opening 806. Once the desired tool orientation is achieved, the delivery sheath 808 (if present) is retracted proximally to expose the collapsed valve 804.
[0084] In FIG. 8B, the tensioning members controlling the release of the downstream end 810 of the outer wall 812 of the valve 804 are partially released while the sutures controlling the inner wall 816 remain under tension. Then, in FIG. 8C, the downstream end 810 of the outer wall 812 of the valve 804 is further released, allowing more of the downstream end, mid-region, and upstream end 814 of the outer wall 812 to expand further, thereby allowing the transition wall 816 of the valve 802 to at least partially expand outward. The partial expansion of the atrial end 814 and ventricular ends 810 of the valve 802 serves to further center and orthogonally orient the mid-region 822 of the valve 802 prior to full release. The initial expansion of the atrial end 814 of the outer wall 812 in this embodiment is a by-effect of the partial release of the ventricular end 810 of the valve 802 as the longitudinal tension is released, although in other examples, independent suture control may be provided.
[0085] In FIG. 8D, the tensioning members at the downstream end 810 and the upstream end 814 are further released, either simultaneously or stepwise alone, to further engage the intermediate region 820 of the outer wall 812 against the valve opening 806. This further expansion of the outer wall 812 exposes the retention barbs or projections 822 on the outer wall 812. The tensioning members may be optionally re-tensioned to re-collapse the valve 804 to facilitate repositioning and / or reorienting the valve 804. Proper centering and orientation of the valve is reconfirmed to ensure that the valve is not deployed tilted or partially dislodged from the valve annulus. Once confirmed, the tensioning members at the inner wall 818 are released, allowing the outer wall 812 to expand unconstrained against the mitral valve opening 806, as shown in FIG. 8E. The sutures are then cut and the cut ends are withdrawn into the catheter, and optionally from the proximal end of the delivery tool 802.
[0086] Additionally, in some variations, one or more rings or wire loops may be attached to the stent structure to facilitate attachment of the tensioning members. The rings may have more rounded surfaces to allow the tensioning members to slide, as opposed to the stent struts. The rings may be fixed directly to the stent structure or may be provided in apertures in the stent structure. The latter configuration allows the rings to move or rotate within the apertures, which may help direct the tension direction between the tensioning members and the attachment areas of the struts. FIGS. 9A-9C show various apertures 904, 906, 908 that may be provided in the stent 900. In these particular examples, the apertures 904, 906, 908 are located on the longitudinal struts 902 of the stent 900, but in other variations, the apertures 1002 may be located along the transverse or circumferential struts 1004 of the stent 1000, as shown in FIG. The ring or wire loop 910, 1010 may have a circular shape, as shown in Figure 10, but in other variations may be oval, square, rectangular, or other polygonal or curved closed shapes. The ring or wire loop may be formed of round wire having a diameter ranging from, for example, 0.001 inch to 0.100 inch, 0.005 inch to 0.050 inch, or 0.007 inch to 0.020 inch, and may have a ring or other shape having a diameter or maximum internal opening dimension ranging from, for example, 0.010 inch to 0.5 inch, 0.010 inch to 0.3 inch, 0.10 inch to 0.1 inch, 0.010 inch to 0.080 inch, 0.015 inch to 0.075 inch, 0.020 inch to 0.70 inch, 0.25 to 0.65 inch. In some variations, the rings attached to the stent structure may be of different sizes to allow for greater variation in the orientation of the tension members depending on size constraints at certain locations. The wires may comprise titanium, stainless steel, nitinol, cobalt chrome, or other biocompatible wires. The wires may be square cut to provide a flat end surface for bonding, or angle cut to increase the surface area for bonding.The wires may be crimped into the apertures and the ends of the wires may be butt-jointed by laser welding. The stent structure and rings may be further processed together, such as by passivation. In some variations, the ring apertures formed in the stent structure may have the same or different cross-sectional shape as the rings, and the relative size may be up to 110%, 120%, 130%, 140%, 150%, 200%, 250%, or 300% of the wire diameter or maximum wire cross-sectional dimension. The location of the ring aperture relative to the end of the strut may be characterized relative to the wire diameter or maximum wire cross-sectional dimension, for example, up to 150%, 200%, 250%, 300%, 400%, or 500% or more from the end of the strut or strut segment.
[0087] FIG. 10 diagrammatically illustrates another embodiment of a stent ring, including a ring 1010 fixedly welded to the ends 1006 of the longitudinal struts 1008 of the stent 1000, a ring 1010 slidably positioned along the circumferential struts 1004, and a ring 1010 positioned in an opening 1002 in the circumferential struts 1010.
[0088] Although embodiments have been particularly shown and described herein with reference to such embodiments, those skilled in the art will recognize that various changes in form and detail may be made therein without departing from the scope of the embodiments. In all of the above-described embodiments, the method steps need not be performed sequentially.
Claims
1. Equipped with an integrated stent frame, The stent frame comprises: A collapsed configuration and an expanded configuration; a plurality of longitudinal struts and a plurality of circumferential struts, wherein the plurality of longitudinal struts include a plurality of longitudinal slots, each of the plurality of longitudinal slots including an elongated barb projecting into each of the plurality of longitudinal slots; a tubular inner wall having a central lumen; Equipped with The replacement heart valve further comprises a replacement leaflet valve disposed in the central lumen of the first wall.
2. 10. The valve of claim 1, further comprising a plurality of closed shapes attached to the stent frame, each of the plurality of closed shapes comprising an inner periphery surrounding a through opening.
3. The valve of claim 2 , wherein the plurality of closed shapes comprises a plurality of rings.
4. The valve of claim 3 , wherein the plurality of rings are circular or elliptical rings.
5. 3. The valve of claim 2, wherein the plurality of closed shapes comprises a plurality of closed wire shapes, each of the closed wire shapes having wire segments welded end-to-end.
6. The valve of claim 5 , wherein the wire segments have a wire diameter or maximum wire cross-sectional dimension.
7. 7. The valve of claim 6, wherein the plurality of closed wireforms are attached to a plurality of stent frame apertures, each of the plurality of stent frame apertures having an aperture diameter no greater than 300% of the wire diameter or a maximum aperture cross-sectional dimension no greater than 300% of a maximum wire cross-sectional dimension.
8. 8. The valve of claim 7, wherein the aperture diameter is no greater than 150% of the wire diameter or the maximum aperture cross-sectional dimension is no greater than 150% of the maximum wire cross-sectional dimension.
9. 8. The valve of claim 7, wherein the stent frame further comprises a plurality of longitudinal struts and a plurality of circumferential struts, the plurality of stent frame apertures being disposed within the longitudinal struts.
10. The valve of claim 8 , wherein the plurality of stent frame openings are disposed at ends of longitudinal struts.
11. The valve of claim 8 , wherein the plurality of stent frame openings are spaced from the ends of the longitudinal struts.
12. 12. The valve of claim 11, wherein the plurality of stent frame apertures are spaced apart from an end of a longitudinal strut a distance greater than 300% of the aperture diameter or 300% of the maximum aperture cross-sectional dimension.
13. the integral stent frame comprises a folded double wall; The stent frame comprises: an outer wall having an open flared region, an intermediate reduced diameter region, and a closed flared region; a transition wall between the outer wall and the inner wall; The valve of claim 2 further comprising:
14. 14. The valve of claim 13, wherein the plurality of closed shapes attached to the stent frame comprises a first plurality of closed shapes attached to the outer wall of the stent frame.
15. 15. The valve of claim 14, wherein the plurality of closed shapes attached to the stent frame further comprises a second plurality of closed shapes attached to the inner wall of the stent frame.
16. 16. The valve of claim 15, further comprising a delivery line slidably attached to each of the first and second pluralities of closed stent configurations.
17. 15. The valve of claim 14, further comprising a delivery line or loop slidably attached to the first plurality of closed stent configurations.
18. The valve of claim 2 further comprising a plurality of pedicled hemispherical tabs projecting longitudinally from the stent frame.
19. a unitary stent frame having a collapsed configuration and an expanded configuration and a tubular inner wall having a central lumen; a replacement leaflet valve disposed within the central lumen of the inner wall; Equipped with The replacement leaflet valve comprises: an annular valve skirt attached to the inner wall of the stent frame; a plurality of leaflets attached to the valve skirt, wherein the leaflets have valve commissures disposed therebetween; Equipped with The replacement heart valve, wherein the tubular valve skirt includes cutouts or openings located between the valve commissures.
20. 20. The valve of claim 19, further comprising a plurality of closed shapes attached to the stent frame, each of the plurality of closed shapes comprising an inner periphery surrounding a through opening.
21. 21. The valve of claim 20, wherein the plurality of closed shapes comprises a plurality of rings.
22. 22. The valve of claim 21, wherein the plurality of rings comprises circular or elliptical rings.
23. 23. The valve of claim 22, wherein the plurality of closed shapes comprises a plurality of closed wire shapes, each of the closed wire shapes having wire segments welded end-to-end.
24. 24. The valve of claim 23, wherein the wire segments have a wire diameter or maximum wire cross-sectional dimension.
25. 25. The valve of claim 24, wherein the plurality of closed wireforms are attached to a plurality of stent frame apertures, each of the plurality of stent frame apertures having an aperture diameter no greater than 300% of the wire diameter or a maximum aperture cross-sectional dimension no greater than 300% of a maximum wire cross-sectional dimension.
26. 26. The valve of claim 25, wherein the aperture diameter is no greater than 150% of the wire diameter or the maximum aperture cross-sectional dimension is no greater than 150% of the maximum wire cross-sectional dimension.
27. 26. The valve of claim 25, wherein the stent frame further comprises a plurality of longitudinal struts and a plurality of circumferential struts, the plurality of stent frame apertures being disposed within the longitudinal struts.
28. 27. The valve of claim 26, wherein the plurality of stent frame openings are disposed at ends of longitudinal struts.
29. 27. The valve of claim 26, wherein the plurality of stent frame openings are spaced from the ends of the longitudinal struts.
30. 30. The valve of claim 29, wherein the plurality of stent frame apertures are spaced apart from an end of a longitudinal strut a distance greater than 300% of the aperture diameter or 300% of the maximum aperture cross-sectional dimension.
31. the integral stent frame comprises a folded double wall; The stent frame comprises: an outer wall having an open flared region, an intermediate reduced diameter region, and a closed flared region; a transition wall between the outer wall and the inner wall; 20. The valve of claim 19 further comprising:
32. 22. The valve of claim 21, wherein the plurality of closed shapes attached to the stent frame comprises a first plurality of closed shapes attached to the outer wall of the stent frame.
33. 33. The valve of claim 32, wherein the plurality of closed shapes attached to the stent frame further comprises a second plurality of closed shapes attached to the inner wall of the stent frame.
34. a plurality of longitudinal slots disposed within the plurality of longitudinal struts; 20. The valve of claim 19, wherein each of the plurality of longitudinal slots includes an elongated barb projecting into each of the plurality of longitudinal slots.
35. 34. The valve of claim 33, further comprising a delivery line slidably attached to each of the first and second pluralities of closed stent configurations.
36. 33. The valve of claim 32, further comprising a delivery line slidably attached to the first plurality of closed stent configurations.
37. 30. The valve of claim 29, further comprising a plurality of pedicled hemispherical tabs projecting longitudinally from the stent frame.
38. a unitary stent frame having a collapsed configuration and an expanded configuration and a tubular inner wall having a central lumen; a replacement leaflet valve disposed within the central lumen of the inner wall; and a plurality of closed configurations attached to the stent frame; Equipped with A replacement heart valve, wherein each of the plurality of closed shapes comprises an inner periphery surrounding a through opening.
39. 40. The valve of claim 38, wherein the plurality of closed shapes comprises a plurality of rings.
40. 40. The valve of claim 39, wherein the plurality of rings are circular or elliptical rings.
41. 40. The valve of claim 38, wherein the plurality of closed shapes comprises a plurality of closed wire shapes, each of the closed wire shapes having wire segments welded end-to-end.
42. 42. The valve of claim 41, wherein the wire segments have a wire diameter or maximum wire cross-sectional dimension.
43. 43. The valve of claim 42, wherein the plurality of closed wireforms are attached to a plurality of stent frame apertures, each of the plurality of stent frame apertures having an aperture diameter no greater than 300% of the wire diameter or a maximum aperture cross-sectional dimension no greater than 300% of a maximum wire cross-sectional dimension.
44. 44. The valve of claim 43, wherein the aperture diameter is no greater than 150% of the wire diameter or the maximum aperture cross-sectional dimension is no greater than 150% of the maximum wire cross-sectional dimension.
45. 44. The valve of claim 43, wherein the stent frame further comprises a plurality of longitudinal struts and a plurality of circumferential struts, the plurality of stent frame apertures being disposed within the longitudinal struts.
46. 45. The valve of claim 44, wherein the plurality of stent frame openings are disposed at ends of longitudinal struts.
47. 45. The valve of claim 44, wherein the plurality of stent frame openings are spaced from the ends of the longitudinal struts.
48. 48. The valve of claim 47, wherein the plurality of stent frame apertures are spaced apart from an end of a longitudinal strut a distance greater than 300% of the aperture diameter or 300% of the maximum aperture cross-sectional dimension.
49. the integral stent frame comprises a folded double wall; The stent frame comprises: an outer wall having an open flared region, an intermediate reduced diameter region, and a closed flared region; a transition wall between the outer wall and the inner wall; 40. The valve of claim 38, further comprising:
50. 50. The valve of claim 49, wherein the plurality of closed shapes attached to the stent frame comprises a first plurality of closed shapes attached to the outer wall of the stent frame.
51. 51. The valve of claim 50, wherein the plurality of closed shapes attached to the stent frame further comprises a second plurality of closed shapes attached to the inner wall of the stent frame.
52. 52. The valve of claim 51, further comprising a delivery line or loop slidably attached to each of the first and second pluralities of closed stent configurations.
53. 51. The valve of claim 50, further comprising a delivery line slidably attached to the first plurality of closed stent configurations.
54. a plurality of longitudinal slots disposed within the plurality of longitudinal struts; 40. The valve of claim 38, wherein each of the plurality of longitudinal slots includes an elongated barb projecting into each of the plurality of longitudinal slots.
55. 40. The valve of claim 38, further comprising a plurality of pedicled hemispherical tabs projecting longitudinally from the stent frame.
56. The replacement leaflet valve comprises: an annular valve skirt attached to the inner wall of the stent frame; a plurality of valve leaflets attached to the valve skirt, wherein valve commissures are provided between the plurality of valve leaflets; Equipped with 39. The replacement heart valve of claim 38, wherein the tubular valve skirt includes cutouts or openings located between the valve commissures.
Citation Information
Patent Citations
Artificial heart valve devices, artificial mitral valves, and related systems and methods
JP2014532457A
System and method for assembling a foldable percutaneous flap
JP2015516254A
Prosthetic valve with expandable frame and related systems and methods
JP2020534944A
Encapsulated heart valve
US20120296418A1
